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ABSTRACT OF THE DISSERTATION
Characterizing nonmodel microorganisms and reconstructing catabolic pathways for bioproductions
by
Whitney Hollinshead
Doctor of Philosophy in Energy, Environmental, and Chemical Engineering
Washington University in St. Louis, 2016

In the 1970s, spikes in oil prices sparked early interests into first-generation biofuels (i.e.,
the production of ethanol from corn). Four decades later, biofuel manufacturing has underperformed as developed industrial strains suffer from poor performance and the high costs of
feedstocks.

While the advancement in molecular biology has greatly benefited our field,

industrial microbial hosts still cannot overcome the obstacles to become profitable bioproduction. One approach may be to study non-model organisms and employ their metabolic
features towards an improved bio-production pipeline. Here, this thesis aims to develop

13

C-

metabolism analysis tools to characterize novel organisms and re-program cell metabolism using
novel pathways for better biosynthesis.
First, the thesis introduces fast 13C-metabolism analysis via parallel 13C-fingerprinting for
pathway delineation as well as quantitative 13C-MFA using WUflux or other published software.
Second, genome-to-phenome mapping was performed for an oil-rich and inhibitor-tolerant
bacterium, Rhodococcus opacus PD630, to improve conversion of lignocellulose to biodiesel.
One major discovery was the simultaneous use of the Entner-Doudoroff pathway (EDP) and
gluconeogenesis for co-utilizing phenolic compounds and sugar without catabolite repression.

x

Third, we analyzed the fastest-growing cyanobacterial strain isolated, Synechococcus
elongatus UTEX 2973, through isotopically non-stationary 13C-Metabolic Flux Analysis. The
flux results indicated that Synechococcus 2973 has efficient catabolic pathways with minimal
carbon loss after CO2 fixation as compared to the model cyanobacterial chassis Synechocystis
6803. These results inspired the engineering of Synechocystis 6803 for improved carbon fixation
efficiency by overexpression of EDP and knockout of CO2 re-generating pathways.
Fourth, the thermodynamically favorable EDP pathway was also engineered in E. coli to
improve carbon utilization and biomass growth. However, the EDP engineering only re-directed
a small portion of its flux, but through a downregulation of Embden-Meyerhof-Parnas Pathway
via pfkA knockout the flux was significantly elevated. Also, the ΔpfkA mutants showed coutilization of acetate and xylose without glucose catabolic repression. Furthermore,

13

C-pulse

experiments suggested a possible presence of glycolysisosome, in which sugar phosphate
metabolites can be passed between enzymes without mixing with the bulk phase. Finally, this
PhD thesis discusses future directions of metabolic engineering and
achieve commercial success with bio-based productions.

xi

13

C-metabolism analysis to

1 Chapter One: Introduction
This chapter was partially adapted from the following publication (full version included in
appendix):
Hollinshead, W.D., He, L., & Tang, Y.J. Biofuel production: an odyssey from metabolic
engineering to fermentation scale-up. Frontiers in Microbiology 5 (2014).

Abstract
Metabolic engineering has developed microbial cell factories that can convert renewable
carbon sources into biofuels. However, there are major roadblocks preventing economical
biofuel/bio-based production among them are low profit margins, limitations imposed by
metabolic burden, and low stability of microbial hosts. These challenges have prompted
metabolic engineers to find and develop new microbial hosts with better productivity, cost
efficiency and improved stability at large-scale bioproductions. With this renewed interest in
non-model microbial hosts, characterization of their metabolism through

13

C-analysis is a

necessity to evaluate their potential and suggest rational engineering strategies. In this chapter,
the background, motivation, and chosen approaches used throughout the thesis are discussed.

Figure 1.1 Feedstocks and products of biofuel producers
1

1.1 Challenges facing Biofuel Industry
Extensive research has been performed on the microbial production of biofuels using
renewable feedstocks (Fig. 1). Ethanol fermentation by yeast is by far the most developed biofuel
process, but low combustion energy and high purification costs prevent the wide use of ethanol
as an economical fuel. Thereby, researchers have engineered microbes to produce new advanced
fuels. Advanced biofuel examples include higher alcohols via the keto-acid and the Ehrlich
pathway (Atsumi et al. 2008), terpene-based fuels (e.g., isopentenol) from the mevalonate
pathway (Withers et al. 2007), fatty acid ethyl esters (Kalscheuer et al. 2006; Steen et al. 2010)
and alkanes from fatty acid biosynthesis pathways (Choi and Lee 2013). Despite the
development of these diverse biofuel producers, it is still challenging to commercialize biofuel
processes due to the poor microbial productivity in large bioreactors and the low profit margins
of biofuels (LaMonica 2014; Zhang 2009). The main carbon source for biofuel production has
typically been obtained from food crops. However, concerns have been raised on linking biofuel
production with food sources. In summary, current molecular biology tools can efficiently alter
enzyme levels to redirect carbon fluxes toward biofuel production, but low product yield and
titer in large bioreactors prevent the fulfillment of cheap biofuels.
1.1.1 Carbon and Energy Metabolism Trade-off
Although current molecular biology tools can effectively alter enzyme levels to redirect
carbon fluxes toward biofuel production, low product yield and titer in large bioreactors have
prevented the fulfillment of cheap biofuels. The high demand of energy and reducing equivalents
during biofuel synthesis is an important obstacle. First, polymerization of protein and DNA/RNA
requires large amounts of ATP (39.1 mmol). Production of biomass, enzymes for biofuel
synthesis, plasmids/mRNA, or synthetic scaffolds consumes not only carbon building blocks, but

2

also energy molecules. Second, large amounts of ATP need to be consumed to support cell
maintenance processes including energy spilling, microbial motility, cell component repair, and
re-synthesis of macromolecules (Hoehler and Jorgensen 2013). Third, the synthesis of biofuel
molecules needs ATP and NAD(P)H. For example, fatty acid production requires 7 ATP and 14
NADPH to convert acetyl-CoA molecules into one fatty acid (Palmitate, C16:0). Use of carbon
oxidation pathways (such as TCA cycle and oxidative pentose phosphate pathway), and
transhydrogenase reactions is necessary to generate sufficient NADPH and ATP for fatty acid
synthesis(He et al. 2014; Varman et al. 2014).
In addition to the high ATP demand imposed by the biofuel synthesis pathways,
metabolic flux analysis studies have revealed that the overexpression of biosynthesis pathways
significantly increases ATP maintenance expenditure(Ow et al. 2009), and the metabolic burden
in engineered microbial hosts further causes poor respiration efficiency (e.g., P/O ratio =
1.3)(Sauer and Bailey 1999; Varma and Palsson 1994). Extensive genetic modifications often
increase metabolic burdens on the host and thus further interfere with cell growth and product
synthesis (Colletti et al. 2011; Poust et al. 2014). For example, high copy number plasmids or
strong promoter can place a heavy burden on the cell’s growth and negatively affect productivity
(Carrier et al. 1998; Jones et al. 2000). If the hosts suffer from severe ATP limitations, efforts to
reduce carbon losses or to increase carbon availability to biofuel synthesis will be futile. In this
case, the metabolic bottleneck may shift from carbon limitation to energy limitation (insufficient
energy molecules to power biofuel synthesis). Many metabolic engineering approaches to
improve carbon efficiency can be effective in redirecting carbon fluxes to biofuel in low
productivity strains (yield far below theoretical value), but these strategies may not raise product
yields close to stoichiometric predictions if the engineered metabolism is unable to satisfy the
3

overall ATP and NAD(P)H requirements by the microbial hosts. Thereby, the priorities toward
high carbon yield and energy efficiency have to be well understood and carefully balanced
during strain development of biofuel producers.
1.1.2 Low Profit Margins of Biofuel
Even once strains are able to balance their energy and carbon metabolism to reach their
theoretical yields with high productivity, they must then contend with reducing their production
costs to be more competitive with petroleum fuels. Currently, biofuels receive subsidies from the
government to offset their costs of production (Hill et al. 2006) but with changing political
environments, that may not always be available. One of the approaches as discussed earlier is the
shifted focus from ethanol to advanced biofuels such as biodiesel and terpenoid compounds that
provide higher energy yields and better environmental benefits than ethanol production (Atsumi
et al. 2008; Fischer et al. 2008; Shen and Liao 2008). In addition, many research labs and
companies have worked to integrate lignocellulose, a potentially cheap feedstock, into biofuel
production to lower costs, but utilizing lignocellulose brings many complications (Keasling
2010; Kim et al. 2010).
Lignocellulose consists of cellulose, hemicellulose, and lignin polymers which after
undergoing a degradation step will release 6-carbon sugars (e.g., glucose), 5-carbon sugars (e.g.,
mannose, galactose, arabinose, and xylose), and toxic aromatics (e.g., phenolics)(Kim et al.
2010).

Using this energy-abundant feedstock with current industrial microbial hosts such as

E.coli and Saccharomyces cerevisiae would require additional engineering or evolution in
addition to the engineering for biofuel production. First, the microbial hosts need to be able to
utilize all of the available carbon sources and for better efficiency be able to utilize them
simultaneously. For example, Saccharomyces cerevisiae cannot natively utilize xylose, and thus

4

has had heterologous xylose catabolic pathways introduced (Zhou et al. 2012). E.coli has native
xylose degradation pathways, but experiences glucose catabolite repression which restricts
xylose consumption until glucose has been depleted. In fed-batch and continuous cultivations,
this causes xylose accumulation and poor biosynthesis efficiency. It is ideal that both carbon
sources be utilized simultaneously, thus increasing the productivity and efficiency of the
bioprocess(Kim et al. 2010). Most studies have needed to disrupt the primary glucose transport
system (PTS), and/or over-express the xylose transporters to force glucose and xylose coutilization (Chiang et al. 2013; Jung et al. 2015; Lu et al. 2016; Su et al. 2015). Lastly, the
biofuel production from engineered microbial hosts is further hampered by the generated toxic
phenolic and other inhibitory compounds released after lignocellulose degradation. They have
been found to reduce growth and product yield (Ezeji et al. 2007). In summary, to widen the
potential profit margin of bio-based productions, in particular for biofuel production, we need
microbial hosts that can efficiently utilize cheaper feedstocks and produce more advanced
biofuels.

1.2 Different microbial platform to make bio-based productions feasible
1.2.1 Cyanobacteria
To overcome energy limitation and high feedstock costs, cyanobacteria are an attractive
microbial platform for the production of high energy biofuels. Cyanobacterial species can
survive in diverse nutrient and light environments. Cyanobacteria contain two photosystems
(PSII and PSI), which forms a linear and a cyclic electron flow to produce ATP and NADPH for
biomass growth and chemical biosynthesis. Under light limiting or impaired phototrophic
conditions, some cyanobacteria may obtain electrons from organic carbons via oxidative pentose
phosphate pathway and the TCA cycle. Some cyanobacteria strains can be integrated with
wastewater treatment to become diverse photo-biorefineries for the productions of chemicals and
5

biofuels. In general, light harvesting cyanobacterial chassis offers a promising approach for
designing cost-effective biorefinery. Recent research studies have successfully engineered model
strains such as Synechocystis 6803 and Synechococcus elongatus PCC 7942 and 7002 for
biofuels such as isopropanol (Kusakabe et al. 2013), butanol (Lan and Liao 2012), and alkanes
(Lindberg et al. 2010). However, the advancement of green cell factories for mass production of
biofuels still has inherent obstacles. First, current model cyanobacteria still have low
productivities due to slower growth and lower cell density than heterotrophs. Second, there is
lack of understanding of cell metabolism in responses to genetic engineering strategies. Lastly, in
photo-biorefinery systems, CO2 mass transfer and light penetration limitations create
heterogeneous growth conditions and micro-environmental fluctuations that lead to non-optimal
conditions for photosynthesis. A novel ‘green’ E. coli, Synechoccocus UTEX 2973, has been
recently isolated and is capable of reaching the highest doubling times reported in
cyanobacteria(~1.9 hrs), a rate similar to Saccharomyces cerevisiae(Yu et al. 2015).

This

cyanobacterium removes some of the barriers in cyanobacteria bioproductions and holds possible
clues to optimize cyanobacterial metabolisms for better growth.

Fluxomic approaches to

rigorously identify these possible influential factors may present rational metabolic engineering
strategies to enhance the metabolism of slow-growing model cyanobacterium, Synechocystis
PCC 6803 for more effective autotrophic and photomixotrophic growth and biosynthesis rates.
1.2.2 Non-model (Heterotrophic) organisms
Current industrial strains can be engineered to improve their conversion of lignocellulose
to biofuel, but many less-studied organisms naturally have beneficial traits for this conversion.
They may have higher tolerance to aromatics, better carbon co-utilization, and higher flux
towards biofuel synthesis pathways (Alper and Stephanopoulos 2009) . Rhodococcus opacus
PD630 is one of the most promising non-model microbes with its high TAG accumulation (up to
6

76% of CDW on gluconate)(Alvarez et al. 1996) and tolerance to lignin-derived aromatics
(phenol) (Yoneda et al. 2016). The strain cannot, however, natively metabolize the other sugars
of lignocellulose: xylose and arabinose but these pathways have been successfully engineered in
the strain (Kurosawa et al. 2015; Kurosawa et al. 2013; Xiong et al. 2012).
As novel organisms are being increasingly isolated and engineered, high-throughput
systems biology techniques should be applied to characterize these strains and further our
understanding of how these strains have evolved to develop these desired features. This is
beneficial to not only the study of these organisms but can be translated into novel strategies to
reprogram model organisms such as E. coli.

1.3

13

C-Metabolism Analysis

Systems biology is used for characterization of microbes and provides guidelines for rational
metabolic engineering. It can be broken into its “Omics” (genomics, transcriptomics, proteomics,
and metabolomics) approaches, which can identify useful mutations, discover gene regulations,
enzyme functions, and measure the metabolite pools in response to environmental fluctuations
(Atsumi et al. 2010; Pham et al. 2006; Redding-Johanson et al. 2011). Although genome-wide
analyses and computational modeling have provided knowledge for the metabolic engineering of
microbial hosts (Park et al. 2008), it is not straightforward to correlate “omics” to actual enzyme
functions due to complex post-transcriptional regulations (such as allosteric regulation)
(Chubukov et al. 2013). For example, increases in mRNA levels may not lead to a corresponding
increase in protein levels, while enzyme levels can remain constant despite frequent changes in
carbon fluxes (Gygi et al. 1999). In addition, the existence of isoenzymes and poor enzyme
specificity contribute to high metabolome diversity and lead to difficulties in metabolomic
studies (Schwab 2003). To overcome such problems, 13C-MFA (metabolic flux analysis) is used
7

to directly measure enzymatic reaction rates. Thereby, metabolic flux analysis tools are required
to provide the most straightforward information on the phenotype. Metabolic flux analysis
determines the turnover rates of a large number of metabolic reactions that participate in the
conversion of carbon sources into biomass building blocks and bio-products in the central
metabolic network. They represent the functional output of the cellular processes responding to
internal or external stimuli. Metabolic fluxes can be studied with Flux Balance Analysis (FBA).
FBA model solutions are based on the stoichiometry of the metabolic reactions in addition to the
measurement of inflow (e.g., substrate uptake) and outflow fluxes (biomass growth and product
synthesis) under a steady state assumption (Eqn 1.1). In addition, a series of physical, chemical,
and biological characteristics (e.g., enzymatic capacity) can constrain the feasible fluxes for a
given physiological condition. The number of constraints in an FBA model is smaller than the
number of reactions in the metabolic network. The model is then underdetermined, and it is
necessary to postulate an objective function (e.g., growth rate maximization) to calculate a set of
predicted fluxes.

max f (vi )
subject to S  v  0
vmin  v  vmax ;
vm  vm,min  vm,max

Eqn. 1.1

where v represents the overall flux values constrained by vmin and vmax, vm are measured fluxes
(inflow and outflow) with same up-bound and low-bound. vk is unknown f(vi) representing the
objective function of a set of vi, and S is the coefficient matrix. A number of strategies are
proposed to improve FBA predictions for cell metabolisms, including incorporation of
thermodynamic principles into FBA (Boghigian et al. 2010), uses of proper objective functions
(e.g., maximizing the biomass) (Schuetz et al. 2007); bi-level optimization approach to describe

8

“non-optimal” metabolism (e.g., trade-off between biomass and product yields) (Burgard et al.
2003); minimization of metabolic adjustment to solve mutant strain fluxes (Boghigian et al.
2010). However, the most rigorous flux analysis combines flux stoichiometry-based balance with
13

C isotopic tracing, i.e.,

defined

13

13

C-MFA.

13

C-experiments consist of feeding the cell culture with a

C-substrate to fingerprint downstream metabolites with isotopomers. The patterns of

isotopic enrichment in metabolites once

13

C distributes throughout the metabolic network can

help decipher flux distributions in the cell metabolism (Tang et al. 2009c). The isotopomer
information allows fluxes in branching (e.g., the pentose phosphate pathway versus glycolysis)
and circular (e.g., TCA cycle) pathways to be determined.

13

C-Metabolic Flux uses the

stoichiometric model to generate possible fluxes, using computational non-linear least-squares
regression algorithms to minimize the difference between the subsequently generated mass
isotopomer distributions(MDVs) of proteinogenic amino acids with the experimental results
(Eqn 1.2).
Minimize ε = (MDVmeas - MDVcalc)2

Eqn. 1.2

Subject to S • v = 0
13

C-MFA requires careful planning of isotopomer labeling experiments and computational

modeling of ordinary differential equations. Two core techniques are used for metabolic flux
analysis: 1) steady state

13

C-MFA discussed earlier and 2) isotopically non-stationary 13C-MFA

which uses labeling kinetics of free metabolites measured using advanced analytical instruments
(such as LC-MS). The mathematical statements can be described as follows (Nöh et al. 2007;
Young et al. 2011):
Minimize ε = (MDVmeas - MDVcalc)2
Subject to S • v = 0
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Eqn. 1.3

ninp
n
n
d (CI )
  v j Pj I  0.5 I T v j Q j I   vinp Pinp I inp
dt
j 1
j 1
inp1

MDVcalc=MIDV-MDV • I
vgrowth= μ Y

Eqn. 1.4
Eqn. 1.5
Eqn. 1.6

where MDVcalc and MDVmeas are the calculated and measured mass distribution vectors of
intermediates, respectively; S is the reaction stoichiometry matrix, and v is the vector of all
fluxes; C denotes a diagonal matrix of intracellular metabolite concentrations; I is the overall
isotopomer distribution vector; Pj is a matrix describing the transitions from reactant to product
isotopomers (isotopomer formation by monomolecular reactions); Qj is a matrix describing the
transitions from reactant to product isotopomers (isotopomer formation by bimolecular
reactions); the sum of the product of Pinp Iinp and vinp (the third term in the equation 2) describes
extracellular reactants (input) to their intracellular counterparts; MIDV–MDV is a matrix that
converts the isotopomer distribution vector I into MDVcalc; vgrowth is the flux to biomass; vsubstrate
is the carbon substrate utilization normalized to 100 units (μmol h-1); μ is the specific growth rate
(h−1); Y is the biomass yield per 100 mole carbon of substrate utilized by the bacteria.
13

C-metabolism analysis is an important tool that can reveal: 1) novel pathways useful for

biosynthesis; 2) rate-limiting factors controlling cell performance; 3) carbon and energy fluxes
through a complex metabolic network.
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2 Chapter Two: Metabolic Flux Analysis through 13C-labeling
This chapter includes some work from the following two publications:
Ruan, Z., Hollinshead, W., Isaguirre, C., Tang, Y.J., Liao, W., & Liu, Y. Effect of inhibitory
compounds in lignocellulosic hydrolysates on Mortierella isabellina growth and carbon
utilization. Bioresource Technology. 2015. 183, 18-24. (I contributed to 13C-labeling Analysis)
Hollinshead, W.D., & Tang, Y.J. He, L., Metabolic Flux Analysis through 13C-labeling.
Methods in Molecular Biology: Microbial Metabolic Engineering. Springer. [Manuscript in
Preparation]. (I have contributed with the drafting of the protocol)
Abstract
13

C-assisted metabolism analysis provides rigorous calculations of the intracellular reaction rates

(i.e., fluxes) within the central metabolism of microbial hosts. This mapping of the intracellular
network within microbes has proven to be essential for understanding the cell physiology. The
approach can identify central metabolic nodes, probe the rigidity of a metabolic network and
reveal hidden pathways. Here we present the methodology of using stable isotopic analogues of
carbon substrates for both qualitative and quantitative (13C-Metabolic Flux Analysis; 13C-MFA)
metabolism analysis.
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2.1 Introduction
There has been a long history of utilizing isotopic tracers to resolve important questions on
cell physiology from DNA synthesis (Meselson and Stahl 1958) to metabolic analysis (He et al.
2014), which now has become the essential backbone of fluxomics, the study of the in vivo
reaction rates. This ‘omics’ toolbox can be applied to many microbes for deciphering the
topology and functionality of their metabolic network. These insights directly link the internal
network of the microbe with its resulting phenotype. In addition, fluxomics can be integrated
with other omics approaches such as genomics and transcriptomics to offer a bottom-up
approach that can exposes internal regulations within the cell.

13

C-metabolism analysis can be

used in a either qualitative or quantitative manner (see Figure 2.1). While

13

C Metabolic flux

analysis (MFA) provides rigorous quantification of microbial flux distributions,

13

C-

Fingerprinting offers a relatively quicker and simpler qualitative method of testing pathway
activities, identifying carbon and nutrient contributions, and calculating true product yields
(Hollinshead et al. 2016; Varman et al. 2014).
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Figure 2.1 13C-Metabolism Analysis: Qualitative vs. Quantitative Approach
As displayed by the above figure,13C-MFA is the quantitative method that expands upon
13

C-fingerprinting to provide precise flux estimates of several central pathways through

mathematical modeling. The theory behind this method lies in an important assumption typically
applicable to batch cultures during the exponential phase and chemostat cultures: that the cells
have reached metabolic steady state. Using the stoichiometry of the metabolic network, the mass
isotopomer distributions (MIDs) of the amino acids, and the extracellular rates, several available
flux softwares will be able to compute close estimates of the flux distribution in the central
metabolism. Despite its wealth of information,

13

C-MFA may not be suitable, if the microbial

strain fails to reach either isotopic and/or metabolic steady state, has a poorly annotated

13

metabolic network, or cannot be cultured without complex or undefined carbon nutrients. In
addition, it typically takes weeks or even months to completely resolve the fluxes by applying
13

C-MFA, thus it is a more labor-intensive and time-consuming project to perform rigorous flux

analysis for multi-strains as compared to 13C-Fingerprinting.
Here, we present an easy-to-follow protocol for 13C-Fingerprinting., the qualitative method,
which using a carefully designed selection of

13

C-tracers can be used to resolve the cell

metabolism without complex flux calculations. First, it can be used to probe the activities of
different pathways if the differing pathways have unique labeling patterns. For example, [1-13C]
glucose has been extensively used to test glycolytic preference between Embden-MeyerhofParnas Pathway (EMPP) and Entner-Doudoroff Pathway (EDP), as the two pathways produce
two distinctly different labeled pyruvates from glucose: a third position 13C-labeled pyruvate and
a first position

13

C-labeled pyruvate, respectively. Second, carbon and nutrient contributions to

biomass synthesis can be easily revealed through the use of a fully labeled primary carbon
substrate (i.e., [U-13C6) glucose) with unlabeled secondary substrates (i.e., yeast extract). The
13

C/12C ratio of the generated biomass provides a measurement of a carbon source’s contribution

to biomass in a mixed-substrate growth medium. Finally, the intrinsic product yield from the
primary carbon source can be calculated based on its measured contribution to the final product.
After your selection of the

13

C-tracers, the method only then requires growth on the

13

C tracer,

amino acid extraction, and determination of mass isotopomer distribution (MID) through mass
spectrometry (see Figure 2.2). In addition to the qualitative approach of

13

C- metabolism

analysis, we will also present the method of quantification of intracellular flux distributions.
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2.2 Materials
2.2.1
1.

13

C-labeling Growth Experiment
C-tracer Selection: The selection of the

13

13

C-tracers is highly dependent on the

organisms of interest, which carbon metabolism is to be studied and which tracer will
provide the most information for flux resolution. Table 1 list the most commonly used
tracers which are available from chemical manufacturers such as Sigma Aldrich (St.
Louis, MO) or Cambridge Isotopes (Tewksbury, MA). Most commonly, the glucose
metabolism of a heterotrophic organism is studied using only a labeled glucose substrate
or a mixture of labeled and unlabeled glucose. For

13

C-MFA approaches, using one

labeled glucose substrate over a mixture leads to better resolution, with the optimal
tracers being [1, 6-13C] glucose, [5,6-13C] glucose, or [1,2-13C] glucose (Crown et al.
2016).
Table 2.1 Commonly Used Tracers
Substrates
Glucose
Acetate
Pyruvate
Amino acids
Others

Commonly Used Tracers
[U-13C6] Glucose or Positional Labeled Glucose (e.g., [1-13C1] Glucose, [2-13C1]
Glucose, [1,2-13C2] Glucose, [1,6-13C2] Glucose, etc.)
[U-13C2] Acetate, [1-13C1] Acetate, or [2-13C1] Acetate
[U-13C3] Pyruvate, [1-13C3] Pyruvate, [1,2-13C2] Pyruvate, etc.
[U-13C3] Aspartate, [U-13C3] Glutamate, etc.
13
C-Formate, 13CO2 or NaH13CO3

2. Media Selection: Rich media often contains complex or even undefined carbon sources
such as yeast extract or casamino acids, which will interfere in both qualitative and
quantitative analysis. Therefore it is necessary to use a minimal media without any major
carbon sources beside the 13C tracer (and 12C tracer as designed for the experiment) or at
least a well-defined media. Although it should be avoided, the addition of vitamin for
growth typically has a negligible effect on the results.
15

2.2.2 Measurement of Growth and Extracellular Rates
1. UV-vis Spectrometer
2. HPLC or enzymatic assay kits for measurement of extracellular consumption and
secretion
2.2.3 Free Metabolite Extraction
1. Liquid nitrogen
2. 100 mL Dewar
3. Methanol-Chloroform (7:3) solution
4. Lyophilizer
2.2.4 Amino Acid Extraction
1. Saline Solution: 0.9 % (wt/vol) NaCl
2. 6N HCl
3. Oven (capable of reaching 100OC)
4. Evaporator: Mini-Vap Evaporator/Concentrator (Sigma Aldrich #22971) or Reacti-Vap
Evaporators (ThermoFisher Scientific TS-18825)
5. Drying Gas: N2 or Air; (see Note 1)
2.2.5 Derivatization and GC-MS Analysis
(Free Metabolite Derivatization)
1. MOX reagent: 20 mg/mL methoxyamine hydrochloride in pyridine (prepared fresh)
2. N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA)
3. GC vials
or
(Proteinogenic Amino Acid Derivatization)
1. Tetrahydrofuran
16

2. N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (TBDMS), 97%
3. GC vials
and
4. Gas Chromatography (Column HP-5MS or DB-5S)-Mass Spectrometer (Alternative
analytical equipment can be used such as NMR, however be careful to match the instrument
with the available input format of your 13C-MFA software.)
5. Amino Acid Standards (Optional) (see Note 2)
2.2.6 Flux Calculation
To reduce modeling challenges, mass spectrum data correction tools and 13C-MFA software
have been developed, including FiatFlux (Zamboni et al. 2005), iMS2Flux (Poskar et al. 2012),
INCA (Young 2014), METRAN (Yoo et al. 2008), OpenFLUX (Quek et al. 2009), OpenMebius
(Kajihata et al. 2014), 13CFLUX (Wiechert et al. 2001) and 13CFLUX2 (Weitzel et al. 2013).
The following table shows comparisons among different

13

C MFA softwares. Researchers may

choose an ideal software based on the purposes of their studies.

Table 2.2 13C-MFA Software (He et al. 2016)
Software
Isotopically
nonstationary
flux analysis
Open-source
Having interface
Flux visualization
Built-in MID
corrections
Tracer simulation
No need to construct
flux model and define
carbon transitions
Reference

INCA

METRAN

WUFlux

OpenFLUX

13CFLUX2





OpenMobius



























(Young
2014)

(Yoo et al.
2008)

(He et al.
2016)

17

(Quek et al.
2009)

(Weitzel et
al. 2013)

(Kajihata et
al. 2014)

Our laboratory has built a

13

C-MFA software, WUFlux, featuring different templates for

bacterial metabolism. WUFlux has a predefined central metabolic network and straightforward
interface and functions for flux map visualization. These features reduce the work required for
users, and thus make WUFlux straightforward to use. On the other hand, if researchers need to
apply isotopically nonstationary flux analysis, we recommend INCA or OpenMebius. These two
softwares have functions for fitting the dynamics of isotopic labeling of metabolites, which is
extremely useful for analyzing the flux phenotype of autotrophic metabolism.

2.3 Methods
2.3.1 Build Metabolic Model
Initially, in order to rigorously calculate the fluxes in the central metabolism, a complete
metabolic model must be developed based on the strain’s genome annotations. This often
restricts this quantitative technique to strains that have been fully sequenced. For information on
which genes are present, the KEGG database is a superior resource. In addition, the carbon
transition within the network needs to be known as well. This is pre-set in WUFlux.
2.3.2 13C-labeling Experiments
1. Prepare a seed culture: Grow the strain in its unlabeled medium into the mid-exponential
phase.
2. Inoculate into the labeled medium at a low inoculation ratio (<0.5 v/v %) (see Note 3).
3. Grow the cells into the mid-exponential phase, and take biomass samples at three or more
time points (see Note 4-5).
4. Centrifuge the samples (7000 rpm, 3min, 4oC), keep the supernatant for extracellular
consumption

and

secretion

measurements,

metabolite/proteinogenic amino acid extractions.
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and

keep

cell

pellets

for

free

2.3.3 Free Metabolite Extraction and Derivatization
1. Add 1 mL of methanol-chloroform (volume ratio 1:1) extraction solution to the cell pellet.
Important: Keep samples cool throughout the extraction.
2. Shake samples (in GC vials) for four hours or overnight at 4OC and 200rpm.
3. Add 0.5 mL of ultra-pure water (the samples should form an aqueous and an organic
layer.)
4. Extract the aqueous layer into new GC vials and freeze-dry the samples using a
lyophilizer. At this step, the dried samples are stable and can be stored at -20OC for
several days to weeks.
5. To derivatize the free metabolites, add 120 µL of MOX reagent and incubate samples at
30OC for 40 minutes.
6. Add 180 µL of MSTFA derivatizing reagent and incubate the mixture at 30OC for 30
minutes. After derivatization, samples should be run on the GC-MS immediately. The
samples typically remained stable for about ~4 hours after derivatization.
2.3.4 Proteinogenic Amino Acid Extraction and Derivatization
1. Wash cells with 1 mL of saline solution.
2. Add 1.5 mL of 6N HCl to cells, and then transfer into GC-vials. Tightly cap the GC vials,
and then place the samples in an oven at 100OC for 18-24 hours.
3. Remove hydrolyzed samples and then cool to room temperature. Transfer the samples to
micro-centrifuge and spin down to remove any cell debris. Evaporate the HCl using an
evaporator (see Note 6). At this step, the dried samples are stable and can be stored at
-20OC for several days to months.
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4. Derivatize the amino acids by adding THF and TBDMS (volume ratio 1:1, and we
recommend 150 µL for either solution). Heat in an oven at 70OC for one hour. Spin down
to remove any debris (see Note 7).
5. Dilute the sample with additional THF if the resulting sample has a dark color. Typically,
the derivatized sample should be a yellow/light brown. A dark color denotes an overly
concentrated sample. Rarely, the sample might turn green; this likely is a very dilute
sample that will require decreasing the split ratio for clear peak data. Derivatized samples
are relatively stable at 4 degrees for 1-3 days, but for best results run samples
immediately after derivatization (see Note 8).

Figure 2.2 13C-Metabolic Flux Analysis Workflow
2.3.5 GC-MS Analysis
Use the following settings for GC/MS analysis or any published analytical method.
Table 2.3 GC/MS settings
20

Parameters
Settings
Split Ratio
1:5 or 1:10
Injection volume
1 μL
Carrier gas
helium=1.2 mL/min
Program:
150OC for 2 minutes
3OC/min to 280OC
20OC/min to 300OC
Hold for 5 min
m/z range:
60-500

The following table shows proteinogenic amino acids that can be analyzed by GC/MS using
TBDMS derivatization (MSTFA-derivatized metabolites not included in this protocol).
Table 2.4 TBDMS-derivatized Amino Acids (see Note 9)
Amino Acid
Precursor
# of carbons M-159/M-85 M-57/M-15
Alanine
PYR
3
158
260
Glycine
3PG, Serine, CO2+methylene-THF
2
218 (M-85)
246
Valine
PYR
5
186
288
Leucine
PYR, AcCoA
6
200
344 (M-15)
Isoleucine
PYR, OAA
6
200
344 (M-15)
Proline
AKG
5
184
286
Methionine
OAA
4
218
320
Serine
3PG, Glycine + methylene-THF
3
288
390
Threonine
OAA, GLX+AcCoA
4
376 (M-85)
404
Phenylalanine
E4P, PEP
9
234
336
Aspartate
OAA
4
316
418
Glutamate
AKG
5
330
432
Lysine
OAA, PYR
6
329
431
Arginine
Glu, CO2
6
340
442
Histidine
R5P, Formyl-THF
6
338
440
Tyrosine
E4P, PEP
9
364
466
2.3.6 Correction for Natural Isotope Abundance
It is necessary to correct the isotopomer distribution data for any influences due to the natural
abundance of isotopes in carbon, silicon, and other elements that comprised the derivatized
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metabolites. Wiechert group (Wahl et al. 2004a) has developed a software to remove this
influence from the data.
2.3.7 Flux Calculations by Using Simple Mass balances
For qualitative analysis, you can generate rough estimates of fluxes using the isotopomer
distribution. For example, using a balance on pyruvate produced through the three different
glycolytic pathways from [1-13C1] glucose, equations 1-3 were developed. If using the
proteinogenic amino acids, the equations can also be used with alanine isotopomer distribution:
Pyr100 =

vEDP
5
2vEDP +2vEMP + 3 vOPPP

(1)

5
3 vOPPP +vEDP +vEMPP
Pyr000 =
5
2vEDP +2vEMP + 3 vOPPP

(2)

Pyr001 =

vEMPP
5
2vEDP +2vEMPP + 3 vOPPP

(3)

where vEDP, vEMPP, and vOPPP are the relative fluxes for the ED pathway, EMP pathway, and
pentose phosphate pathway, respectively. Ixxx is the fraction of the isotopomer, with 1 denoting
the carbon position of

13

C (e.g., I001 is the abundance of pyruvate labeled at carbon position 3).

These equations assume no reversibility of reactions and ignore the influence of intersecting
pathways (e.g., cataplerotic pathways and biomass formation). The above equations are a balance
on pyruvate production from the three glycolytic pathways: the ED pathway, EMP pathway, and
the pentose phosphate pathway. As shown in the graph below, the fluxes generated for a ΔptsG E.
coli mutant through these simple balances on pyruvate can significantly differ from those
calculated by a

13

C-MFA software like WUFlux for the node reactions G6P->F6P (encoded by

pgi), 6PG-> R5P (encoded by g6pdh), and 6PG->KDPG (encoded by edd).
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WUFlux
Simple Balance
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34%
64%
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0
EMPP

OPPP

EDP

Glycolytic pathways
Figure 2.3 Comparison of fluxes determined by Equations (1-3) and those by 13C MFA
2.3.8 Flux Calculations by Using WUFlux
Here, we demonstrate the general procedures of performing

13

C MFA with WUFlux. For the

detailed information, please read the user manual of WUFlux at http://www.13cmfa.org/.
1. Choose a template. Click ‘Metabolic Reactions’, and then select one template from those for
chemoheterotrophic bacteria, photomixotrophic/photoheterotrophic cyanobacteria, or vanillindegrading bacteria. The following figure shows a screenshot of choosing a model template in
WUFlux.
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Figure 2.4 Template selection in WUFlux
2. Edit metabolic reactions. As shown in the above figure, WUFlux will display central
metabolic reactions, which includes the Embden–Meyerhof–Parnas pathway, the oxidative
pentose phosphate pathway, the Entner–Doudoroff pathway, the TCA cycle, the Calvin cycle
(only in the cyanobacterial template), the C1 (including 5-methyl-tetrahydrofolate and 5,10methylene-tetrahydrofolate) metabolism pathway and the anaplerotic pathway. Researchers can
modify the metabolic network by knocking out reactions that are not present in the bacterial
metabolism, changing the boundary conditions and defining the reversibility of reactions based
on the gene annotations. (See Note 10)
3. Input experimental data. To import experimental data, click the button ‘Experimental Data’.
Two types of experiment data are required: the MIDs of metabolites and labeled substrates. As
for the MIDs, users can either import the data from an Excel file, or input the data manually.
Each carbon atom of labeled substrate should be defined as the relative abundance of

13

C atom.

For example, define [1,2-13C2] glucose as [1,1,0,0,0,0] for the corresponding six carbon atoms,
where the first ‘1’ means the first carbon atom of glucose is 100%
24

13

C-carbon. In addition, two

data types are optional: the nonlabeled biomass percentage and the measured fluxes. The former
is used to remove the non-labeled

12

C-carbon noises introduced from bacterial inoculation, and

the latter can help accurately determine the intracellular fluxes. We recommend users to consider
these two factors when the initial non-labeled biomass in the labeled culture is high or any
byproduct is significantly produced by the microorganism.
4. Customize optimization settings. To modify parameters for optimization and statistics, click
‘Settings’ and then make changes. The MATLAB built-in function ‘fmincon’ is used to solve the
nonlinear optimization problem. The parameters, TolFun, TolCon, TolX, MaxIter, and MaxFun,
have

the

same

meanings

as

described

on

the

website:

http://www.mathworks.com/help/optim/ug/fmincon.html. The default algorithm of the ‘fmincon’
solver is ‘interior-point’. To get the global optimum, 10 or multiple initial guesses are
recommended. In addition, the Monte Carlo method is employed to calculate the confidence
interval of fluxes. In this method, WUFlux perturbs the measured data with normally distributed
noises, whose averages (µ) are zero, and standard deviations (δ) are based on the experimental
results.
5. Optimize the flux distributions. To calculate the intracellular flux distributions, click ‘Run’,
and a pop-up window will appear to show the progress of the on-going calculation. All the flux
calculations starting from each initial guess will be stored in the file. Once finished, another
window will appear: Either click ‘Yes’ to continue calculating confidence intervals, or click ‘No’
to stop the calculation for the time being. The ‘Start’ button changes to the ‘Continue’ button,
and you can resume calculating confidence intervals later.
6. Visualize the results. Click ‘Results’ to see the best fit of flux distributions, confidence
intervals, and standard deviations. A figure showing the correlation of measured and simulated
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MID data will be automatically generated on the right side. Additionally, the χ2 test can be
applied to determine the goodness of fit (shown at the bottom line), which can be used as a
reference to determine whether the final fitting is statistically acceptable. The interface also has a
‘Remove results’ button, which allows you to remove the current flux results. However, once
deleted, the results cannot be recovered.

Figure 2.5‘Results’ in WUFlux

To visualize the flux results with respect to constructed metabolic network, click the button
‘Generate a flux map’. WUFlux will generate a flux map in a svg file. Further, to see the
comparison between the simulated and experimental MID of a certain ion fragment, click
‘Generate an MID figure’ and then choose the corresponding ion fragment.

2.4

Notes

1. N2, an inert gas, is a preferred drying gas, though air is a cheaper alternative.
2. Standards can be helpful for accurate peak identification; however, a cheaper alternative is to
process an unlabeled biomass sample in parallel to identify the relevant retention times.
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3. For qualitative analysis, the inoculation ratio can be as high as 1 or 2% (v/v).
4. Typically for E. coli, we harvest 5 mL of cultures at OD600 ~1.0. Only 5 mg of biomass is
necessary for amino acid detection via GC-MS analysis. Biomass can be stored at -20OC.
5. Due to the fast turnover of free metabolites, it is best to quench the cells (i.e., halt the
metabolism) to avoid sudden metabolite changes due to changing environmental conditions.
Quenching can be completed through fast filtration, cold solvent (ethanol or methanol), or
cold media. Our preferred method is a combination of cold media (devoid of carbon sources)
with liquid nitrogen as a coolant.
6. Large particles will clog the needle of the GC-MS, so closely examine samples prior to GCMS run for any remaining cell debris.
7. If the samples appear a dark brown/black color, it is likely that the biomass amount was too
high. At this stage, you can dry down 0.5 or 1 mL of the hydrolyzed sample to cut the time.
8. It is ideal to avoid loading concentrated samples; this will cause oversaturated MS signals
which leads to an inaccurate isotopomer data.
9. Cysteine and Tryptophan cannot be measured through this technique. Glutamine and
Asparagine are reduced in this method to Glutamate and Aspartate, respectively. Due to their
low abundance, these amino acids may be difficult to analyze in dilute samples: Methionine,
Threonine, Arginine, and Histidine. In addition, if peaks appear to co-elute with other
compounds, it may be necessary to decrease the temperature ramp for better elucidation.
General signs of interference from other compounds are a high M-1 peak.
10. In WUFlux, a new reaction in the central metabolism cannot be added in the template, and
all the carbon transition fates have been pre-defined. But users can add product formation
reactions in the ‘Metabolic reactions’ section.
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2.5 Example Case Study: Examine carbon utilization of lignocellulosic
hydrolysates in Mortierella Isabellina
Mortierella isabellina is an oleaginous fungus that can grow on lignocellulosic sugars:
acetate, glucose, and xylose. To further understand its carbon utilization while grown on
lignocellulosic hydrolysates, we designed parallel

13

C-labeling experiments using the protocol

described previously where we grew three identical sets of cultures with only one carbon
substrate fully

13

C-labeled (glucose, xylose, and acetate) (Ruan et al. 2015). In addition to the

three substrates, the cells were also provided yeast extract and exposed to lignocellulosic
inhibitors: furfural and HMF. In combination, the experiments provided a view of each carbon’s
contribution to biomass when grown with lignocellulosic hydrolysates and its common inhibitors
(see Fig. 2.4). The results from

13

C-fingerprinting experiments showed a significant carbon

contribution from yeast extract, an added component to the media as a source of nitrogen. That
glucose was the next most-utilized source for proteinogenic amino acids, in particular for alanine.
Acetate served as a main source for TCA-derived amino acids, aspartate and leucine, with little
incorporation into alanine and phenylalanine (total acetate/13C% were <5%). The labeling results
were also an additional confirmation to sugar consumption measurements that while the strain is
able to simultaneously utilized glucose and acetate, xylose is not heavily used while glucose is
present.
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Figure 2.6 Isotopomer Labeling of Amino Acids
Data was determined from three different tracer experiments, in which only one tracer of
glucose, xylose, and acetate was fully labeled accordingly. The biomass samples were from the
middle-log growth phase in which all three substrates were present. (2) Yeast extract also
contributed to amino acid synthesis.
Further, to investigate the carbon contributions to lipid synthesis, the labeling in the lipids
were measured (see Fig. 2.5). There is a high incorporation of acetate into lipids (36% of lipid
synthesis), despite a lower provided concentration (2 g/L) then glucose in the media (10 g/L). In
fungi, acetyl-CoA (lipid precursor) synthesis and TCA cycle occur within the mitochondrion,
while lipid biosynthesis occurs within the cytosol(Shuler and Kargi 2002). Thus, supplying
acetate in the media likely enhances acetyl-CoA levels within the cytosol, and facilitates lipid
accumulation in Mortierella isabellina.
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Figure 2.7 Carbon Contribution to Lipid Synthesis

Carbon source distribution in lipids determined via 13C-carbon tracing analysis. (1) The biomass
sample was from the middle-log growth phase when all three substrates were present. (2) Yeast
extract also contributed to lipid synthesis.
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3 Chapter Three: Rapid metabolic analysis of Rhodococcus opacus
PD630 via parallel 13C-metabolite fingerprinting
This chapter has been reproduced from the following publication:
Hollinshead, W.D., Henson, W.R., Abernathy, M., Moon, T.S., & Tang, Y.J. Rapid metabolic analysis of
Rhodococcus opacus PD630 via parallel 13C-metabolite fingerprinting. Biotechnology and Bioengineering.
113 (1):91-100 (2016). (I contributed to metabolism analysis via 13C labeling in this paper.)

Abstract
For rapid analysis of microbial metabolisms,

13

C-fingerprinting employs a set of tracers to

generate unique labeling patterns in key amino acids that can highlight active pathways. In
contrast to rigorous

13

C-metabolic flux analysis (13C-MFA), this method aims to provide

metabolic insights without expensive flux measurements. Using

13

C-fingerprinting, we

investigated the metabolic pathways in Rhodococcus opacus PD630, a promising biocatalyst for
the conversion of lignocellulosic feedstocks into value-added chemicals. Specifically, seven
metabolic insights were gathered as follows: (1) glucose metabolism mainly via the EntnerDoudoroff (ED) pathway; (2) lack of glucose catabolite repression during phenol co-utilization;
(3) simultaneous operation of gluconeogenesis and the ED pathway for the co-metabolism of
glucose and phenol; (4) an active glyoxylate shunt in acetate-fed culture; (5) high flux through
anaplerotic pathways (e.g., malic enzyme and phosphoenolpyruvate carboxylase); (6) presence
of alternative glycine synthesis pathway via glycine dehydrogenase; and (7) utilization of
preferred exogenous amino acids (e.g., phenylalanine). Additionally, a 13C-fingerprinting kit was
developed for studying the central metabolism of non-model microbial species. This low-cost kit
can be used to characterize microbial metabolisms and facilitate the design-build-test-learn cycle
during the development of microbial cell factories.
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3.1 Introduction
Over the past decades, model organisms such as Escherichia coli and Saccharomyces
cerevisiae have been engineered to produce diverse products. However, such model organisms
have struggled to become industrial platforms for producing biochemicals because of the poor
stability of heterologous enzymes, low product yields and titers, and the high cost of feedstocks.
An alternative approach is to develop a non-model chassis that natively contains a desired
pathway or tolerance to substrates and products (Alper and Stephanopoulos 2009). Non-model
organisms that require only minor modifications to native pathways and regulations could
improve biosynthesis yields, leading to cost-effective commercial biorefineries. The first step
towards development of such a new microbial chassis is to understand their metabolism. Recent
advances in whole genome sequencing as well as RNA profiling and proteomics have lowered
the time and cost of analyzing organisms, leading to a rapid growth of functional genomics
(Suthers et al. 2009). However, unknown mechanisms of post-transcriptional and posttranslational regulations still limit our ability to connect microbial “omics” with actual
phenotypes (Chubukov et al. 2013; Gygi et al. 1999). Fluxomics can fill this gap by directly
probing enzyme functions.
13

C-Metabolic Flux Analysis (13C-MFA) can estimate in vivo reaction rates in microbial

central metabolisms. A typical MFA protocol includes chemostat cultures using

13

C-labeled

substrates, measurement of extracellular metabolite concentrations, determination of biomass
compositions, isotopomer analysis of amino acids or free metabolites, development of a
metabolic model, and flux calculations.

The method can pin-point bottleneck steps in a

metabolic network and guide metabolic engineering approaches (Fig. 3.1) (Au et al. 2014;
Crown and Antoniewicz 2013b; Long and Antoniewicz 2014).
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Figure 3.1 13C-MFA and 13C-fingerprinting for rational metabolic engineering
Technical advances in DNA synthesis allow for rapid assembly of a metabolic pathway (often
within a week). Thus, the need of time-efficient

13

C-metabolism analysis along with other

“omics” tools has become essential to address issues resulting from multiple interactions
between pathways, which ultimately plays an important role in the iterative design-build-testlearn cycle during rational metabolic engineering.

However, this quantitative determination of flux values in a metabolic network can be
time consuming. High throughput

13

C-MFA methodology and equipment are being developed

(Fischer and Sauer 2005; Heux et al. 2014), which may reduce the cost for mutant
characterizations during the design-build-test-learn cycle of metabolic engineering. Another
roadblock is that traditional

13

C-MFA cannot characterize many microbial systems precisely: 1)

microbial species that cannot grow in a minimal defined medium; b) cultures that cannot achieve
a strict metabolic steady state (e.g., biomass compositions of Rhodococcus change due to the
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accumulation of intracellular lipids); c) consortium or microbial species with sub-populations
(e.g., engineered microbes often contain both plasmid-containing cells and plasmid-free cells); d)
13

C-tracers for metabolism analyses (e.g.,

13

C-phenolic compounds for studying aromatic

substrate utilization) are commercially unavailable or prohibitively expensive. The CeCaFDB
database indicates that less than 100 13C-MFA papers were published on non-model microbes in
the past 20 years (Zhang et al. 2015).
Alternatively,

13

C-tracing via multiple-tracers may elucidate the enzyme activities or

measure intrinsic biosynthesis yields in a more time-efficient manner (Buescher et al. 2015;
Varman et al. 2014). In the past, parallel labeling experiments have been used to investigate
specific pathways (such as TCA cycle or glycolytic pathways) (Crown and Antoniewicz 2013a)
or improve

13

C-MFA accuracy (Crown et al. 2015). In our study, we designed a more

comprehensive set of tracer experiments to delineate the overall central metabolism of a poorly
understood microbe. Via a 13C-“fingerprint” (i.e., the labeling distributions of key proteinogenic
amino acids), we can compare and examine almost all central pathways. As a simplified version
of

13

C-MFA, this method eliminates the need to measure concentrations of extracellular

metabolites and biomass compositions or metabolic modeling for flux calculations (reducing the
restrictions on culture medium and culture states). In addition,

13

C-experiments that include

combinations of labeled and unlabeled substrates can elucidate unknown pathways and their
importance within a non-model organism’s central metabolism. 13C-fingerprinting is particularly
valuable for qualitatively analyzing poorly-understood microbial species at low costs. As a case
study, we applied

13

C-fingerprinting to investigate the central metabolism of Rhodococcus

opacus PD630, a promising biocatalyst to convert diverse feedstocks into triacylglycerol.
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The Rhodococcus genus contains species that are found in many diverse environments,
including water, termite guts, and contaminated soils (Bredholdt et al. 2007; McLeod et al. 2006;
Whyte et al. 2002). R. opacus PD630 was isolated from contaminated soil at a gas works plant
(Alvarez et al. 1996), and it has demonstrated high tolerance to industrial solvents, such as
benzene and toluene (Nakashima et al. 2005; Paje et al. 1997; Zaitsev et al. 1995). It is
hypothesized that its solvent tolerance is due to its unique lipid metabolism and capacity for
triacylglycerol accumulation(Urbano et al. 2014). This species can accumulate up to 70-80% of
its cell dry weight as triacylglycerol (TAG)(Alvarez et al. 1996). When grown on three different
lignocellulose hydrolysates, PD630 was able to maintain growth and accumulate TAG(Wang et
al. 2014). In addition, Kurosawa et al. have developed genetic tools to engineer this strain for coutilization of glucose and arabinose, making R. opacus PD630 a promising workhorse for
lignocellulosic biofuel production(Kurosawa et al. 2015). To further explore this strain’s
potential, we used

13

C-fingerprinting to have a better understanding of its annotated metabolic

network (Holder et al. 2011).

3.2 Results
3.2.1

Growth of R. opacus PD630 on different carbon substrates
One of the most promising characteristics of R. opacus is its ability to grow on a variety

of carbon substrates, including toxic aromatics. To delineate the effect of each carbon source, R.
opacus was grown in 5 mL of tracer media. These growth experiments can offer preliminary
information on bacterial carbon utilizations. As shown in Table 3.1, the culture with glucose and
yeast extract had the highest growth rate (0.25 hr-1) while the acetate culture had the lowest
growth rate (0.16 hr-1). The culture with both glucose and phenol did not show a reduced growth
rate (0.22 hr-1), compared to that of the culture with glucose only (0.19 hr-1). Moreover, addition
of other substrates (i.e., glyoxylate and malate) to glucose cultures did not inhibit cell growth.
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Table 3.1 Tracer experiments for 13C-fingerprinting in R. opacus PD630
Pathway

Growth Substrate

Growth Rate
(hr-1)

Amino acid
uptake
Acetate
metabolism

5 g/L U-13C6 glucose + 0.5 g/L
yeast extract

0.25±0.02

2.5 g/L 1-13C1 acetate

0.16±0.01

5 g/L U-13C6 glucose + 1 g/L
NaHCO3

0.24±0.01

5 g/L 1-13C1 glucose

0.19±0.01

CO2 fixation
Glucose
metabolism
Glyoxylate
shunt
Glyoxylate
shunt

5 g/L U-13C6 glucose + 0.5 g/L
glyoxylate
13
2.5 g/L U- C2 acetate + 0.5 g/L
glyoxylate
13
5 g/L U- C6 glucose + 0.5 g/L
Malic enzyme
malate
13
Phenol co5 g/L U- C6 glucose + 0.5 g/L
metabolism
phenol

13

C-fingerprints in key
amino acids
12
C abundance in amino
acids
13
C labeling in Ala, Asp,
Glu, Gly, Ser
13
C labeling in Ala, Asp,
Glu
13

C labeling in Ala

12

0.24±0.01
0.20±0.03
0.21±0.01
0.22±0.01

C abundance in Ala, Asp
and Gly
12
C abundance in Ala, Asp,
Gly, Phe
12
C abundance in Ala, Asp,
Phe
12
C abundance in Ala, Asp,
Glu, Phe, Ser

3.2.2 Glucose catabolic pathways in R. opacus PD630
Glucose can be catabolized into pyruvate by three routes: the Embden-Meyerhof pathway
(EMP), the pentose phosphate (PP), and the Entner-Doudoroff (ED) pathways (Fig. 3.2). The
EMP produces two ATP and two NADH molecules per glucose molecule. In conjunction with
the EMP, the PP pathway synthesizes C4/C5 building blocks and replenishes NADPH supply.
The

first

step

of

the

PP

pathway converts

glucose-6-phosphate

(G6P)

into

6-

phosphogluconolactone (6PG) via glucose-6-dehydrogenase. 6PG acts as a branching metabolite
between the oxidative PP pathway (6PG  ribulose 5-phosphate + CO2) and the competing ED
pathway. The ED pathway relies on 6PG dehydratase and 2-keto-3-deoxyphosphogluconate
aldolase, which has a net yield of one ATP, one NADH, and one NADPH per glucose molecule.
1-13C glucose can be used to distinguish the relative flux between the three glucose
degradation pathways by analyzing the labeling of alanine (a pyruvate-derived amino acid)
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(Klingner et al. 2015). As shown in Fig. 2, EMP pathway of 1-13C glucose produces one
unlabeled pyruvate molecule and one pyruvate molecule labeled at carbon position 3 (i.e., 50%
of alanine will be labeled on its third carbon, and 50% of alanine will not be labeled). If 1-13C
glucose is metabolized via the oxidative PP pathway, the labeled carbon will be lost, resulting in
unlabeled pyruvate(Borodina et al. 2005). In contrast, the ED pathway produces pyruvate labeled
at position 1 (i.e., 50% of alanine is labeled on its first carbon, and 50 % of alanine is not
labeled). In this study, alanine was labeled at position 1 (~47%). Eq. 2-4 shows ~93% of glucose
was catabolized via the ED pathway, while the EMP (~2%) and the PP pathway (~5%) had low
activity. The ED pathway can also be revealed by serine labeling (derived from GAP, Fig. 2).
When 1-13C glucose was used by R. opacus, the resulting serine was almost unlabeled (M0>95%,
Supplementary Table S1), confirming low EMP pathway flux. For comparison, E. coli has low
activity of its ED pathway(Zhao and Shimizu 2003b). A control experiment confirmed that
alanine from E. coli culture with 1-13C glucose was labeled at its third position (Fig. 3.2).
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Figure 3.2 1-13C glucose catabolism via the ED, EMP, and oxidative PP pathways
The relative amounts of three key isotopomers of alanine were calculated based on GC-MS data
([M-57]+, [M-159]+, and f302 peaks). Alanine from R. opacus was mainly labeled at its first
13

position or unlabeled. *: Alanine resulting from 1- C glucose culture of E. coli BL21 (as a
control) was mainly labeled at its third position. Abbreviations: KDPG, 2-keto-3-deoxy-6phosphogluconate; GAP, glyceraldehyde-3-phosphate; PYR, pyruvate; FBP, fructose-1,6biphosphate; DHAP, dihydroxyacetone phosphate; Ru5P, ribulose-5-phosphate.
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3.2.3 Activation of glyoxylate shunt in acetate metabolism in R. opacus PD630
The glyoxylate shunt utilizes isocitrate lyase and malate synthase, eliminates the loss of
carbon as CO2, and replenishes the TCA cycle with intermediate metabolites (Fig. 3.3). To detect
whether the glyoxylate shunt was active, R. opacus was cultivated in fully labeled glucose (U13

C) with unlabeled glyoxylate. Analysis of the resulting amino acids showed that oxaloacetate-

derived Asp was almost fully labeled (two-carbon labeled Asp M2 below 5%), indicating low
glyoxylate shunt activity in glucose-fed cultures (Table 3.2). Changing the primary carbon
source to acetate (i.e., fully labeled acetate and unlabeled glyoxylate) significantly up-regulated
the glyoxylate shunt to co-utilize glyoxylate, as shown by the isotopic dilution of Asp. The
incorporation of unlabeled carbons from glyoxylate into malate also leads to isotopic dilutions of
pyruvate-derived alanine, indicating pyruvate shunt activity. In bacteria, isocitrate lyase has a
much lower affinity for isocitrate than isocitrate dehydrogenase in the TCA cycle. However,
acetate metabolism deactivates isocitrate dehydrogenase and thus increases isocitrate channeling
through the glyoxylate shunt (Zhao and Shimizu 2003b).
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Figure 3.3 Metabolic network of Rhodococcus opacus PD630
Central pathways include EMP, pentose phosphate pathway (PPP), ED pathway (green arrows),
glyoxylate shunt, anaplerotic pathways (blue arrows), and the TCA cycle. Phenol is degraded
into SucCoA and Acetyl-CoA (red arrows) that can be used for growth and lipid biosynthesis
(Holder et al. 2011). Labeling patterns for cultures with glucose and phenol as carbon sources
suggest that the use of the ED pathway for glucose metabolism allows for gluconeogenesis via
the EMP pathway (purple arrows). Dotted lines represent pathways for amino acid biosynthesis.
Abbreviations: α-KG, α-ketoglutarate; GLX, glyoxylate; ICIT, isocitrate; MAL, malate; OAA,
oxaloacetate; PEP, phosphoenolpyruvate; SUC, succinate; SucCoA, succinyl-CoA.
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As seen in cultures grown in 1-13C acetate only, the labeling of alanine is similar to that
of serine and serine-derived glycine (Table 3.2). However, cultures fed with both fully labeled
acetate and unlabeled glyoxylate resulted in glycine with unusually high abundances of M 0
(0.57). Similar observation was also found in the U-13C Glucose culture with unlabeled
glyoxylate (i.e., M0 in glycine was much higher than M0 of other amino acids, such as Asp). This
large M0 of glycine indicates a direct conversion of glyoxylate to glycine in the presence of
extracellular glyoxylate. A unique glycine dehydrogenase in Mycobacterium species has been
discovered to convert glyoxylate to glycine(Boshoff and Barry 2005), which is involved in redox
balancing and intracellular detoxification of fatty acid by-products in Mycobacterium
species(Giffin et al. 2012). However, this reaction is not annotated in the R. opacus KEGG map.
A search using the KEGG genome database shows two genes that are annotated as glycine
dehydrogenases, LPD04987 and LPD07163. They share a 77% and 63% protein sequence
identity to the glycine dehydrogenase found in M. tuberculosis (mtu:Rv1832), respectively. We
performed RT-PCR to determine whether the annotated glycine dehydrogenases were actually
transcribed in R. opacus. As shown in Figure 3.4, both candidate genes of glycine dehydrogenase
were expressed (especially for LPD04987).
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Table 3.2 MS data ([M-57]+) in key non-fragmented amino acids resulting from 13Cfingerprinting
Labeled
Substrate

U-13C
Glucose

13

U- C
Acetate
1-13C
Acetate

Unlabeled
Substrate

Amino
Acid
Asp
Bicarbonate
Ser
Ala
Asp
Phe
(M0Malate
M4)
Phe
(M5M9)
Ser
Asp
Ser
Glyoxylate
Ala
Gly
Asp
Ala
Glyoxylate
Ser
Gly
Ala
None
Gly
Ser

M0

M1

M2

M3

0.00±0.01
0.01±0.01
0.15±0.02
0.24±0.04

0.00±0.01
0.00±0.01
0.02±0.01
0.03±0.01

0.01±0.01
0.03±0.01
0.04±0.01
0.05±0.01

M4

0.11±0.01 0.87±0.01
0.96±0.01
0.79±0.02
0.13±0.01 0.56±0.05

0.02±0.01 0.03±0.01 0.01±0.01 0.02±0.01 0.06±0.01

0.02±0.01 0.05±0.01 0.05±0.01 0.08±0.01 0.67±0.04
0.11±0.02
0.01±0.01
0.01±0.01
0.01±0.01
0.08±0.01
0.10±0.01
0.21±0.01
0.44±0.01
0.57±0.01
0.40±0.02
0.42±0.02
0.41±0.02

0.03±0.01
0.00±0.01
0.02±0.01
0.01±0.01
0.03±0.01
0.13±0.01
0.05±0.01
0.07±0.01
0.06±0.01
0.59±0.02
0.59±0.02
0.59±0.02

0.05±0.01
0.05±0.01
0.04±0.01
0.04±0.01
0.89±0.01
0.16±0.01
0.32±0.01
0.07±0.01
0.38±0.01
0.01±0.02
0.00±0.02
0.00±0.02

0.81±0.02
0.15±0.01 0.80±0.01
0.94±0.01
0.95±0.01
0.14±0.01 0.46±0.01
0.42±0.01
0.42±0.01
0.00±0.02
0.00±0.02

* Mass standard deviations are estimated based on two replicate samples (n=2). The instrumental
errors of GC-MS measurement were below 0.02. Note: Unlike
analyses depend on labeling data from only a few key amino acids.

42

13

C-MFA,

13

C-fingerprinting

Figure 3.4 RT-PCR results for the annotated glycine dehydrogenases.
Figure is a representative image of RT-PCR experiments (biological duplicate for cultures grown
in 5 g/L glucose and 0.5 g/L glyoxylate). Lane 1, size ladder (150, 200 nt, etc. from the bottom);
Lane 2, LPD07163 (195 nt); Lane 3, LPD04987 (193 nt); and Lane 4, reference gene LPD05856
(positive control, 146 nt). No band was observed from negative control samples (control without
template).

3.2.4 Activities of anaplerotic pathways and malic enzyme in R. opacus PD630
Anaplerotic pathways allow heterotrophs to fix CO2, regulate the cofactor balance, and
replenish TCA metabolites. The enzymes responsible for the anaplerotic pathways are the malic
enzyme, phosphoenolpyruvate carboxylase, and pyruvate carboxylase. If the anaplerotic
reactions are absent in microbial hosts, cell metabolism has to employ glyoxylate shunt to
regulate the TCA cycle(Peng et al. 2004). To investigate the anaplerotic activity, fully labeled
glucose and unlabeled bicarbonate were used to detect R. opacus CO2 fixation (Table 3.2), which
would lead to a labeling dilution in TCA cycle metabolites. Isotopomer analysis indicates that
the oxaloacetate-derived Asp displayed 11% M3 (i.e., one carbon of Asp was from unlabeled
CO2), and very little labeling dilution was seen in Ala or Ser. This indicates that CO2 fixation is
likely through the phosphoenolpyruvate carboxylase (PEPC) or pyruvate carboxylase.
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On the other hand, the malic enzyme allows the exchange of TCA intermediates with
pyruvate for NADPH generation. The malic enzyme activity was revealed using fully labeled
glucose and unlabeled malate (Table 3.2). The labeling in Asp was highly diluted from the
incorporation of unlabeled malate through the TCA cycle. Labeled alanine also became diluted
with an abundance of 0.15 for M0, indicating pyruvate shunt activity. The dilution in the labeling
of serine (derived from glyceraldehyde 3-phosphate) and phenylalanine (derived from
phosphoenolpyruvate, PEP) supports the activity of PEP carboxykinase (PEPCK), which
converts oxaloacetate into PEP. Since the PYR-to-PEP conversion is thermodynamically
unfavorable (Zhao and Shimizu 2003b), PEPCK is likely a key route to pump carbons from the
TCA cycle into upper glycolysis intermediates in R. opacus PD630.
3.2.5 Amino acid and phenol utilization in R. opacus PD630
Microbial preference for using exogenous amino acids is associated with their ABCtransporters(Zhuang et al. 2011). To explore this preference, cells were grown with fully labeled
glucose and unlabeled yeast extract. In this rich medium, cell growth was ~25% faster (Table
3.1). As shown in Fig. 4, 66% of the carbon from Phe was incorporated from unlabeled yeast
extract at the mid-exponential phase, likely due to the strain’s ability to transport aromatic
compounds (e.g., benzoate) inside the cell for growth. The data also shows exogenous uptake of
Tyr (41%), another aromatic amino acid (Fig. 3.5). Furthermore, addition of 0.5 g/L Phe into
glucose (5 g/L) medium increased the final biomass (at stationary growth phase) by 26%,
indicating R. opacus’ capability to catabolize Phe as the secondary carbon source.
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Figure 3.5 The use of exogenous amino acids from yeast extract by R. opacus
13

From a tracer experiment (U- C glucose) with unlabeled yeast extract, the

12

C % abundance

represents the percentage of carbon that is not derived from glucose. Error bars represent
standard deviations from GC-MS measurements (n=2).

R. opacus can grow on toxic aromatics primarily via the β-ketoadipate pathway
(Harwood and Parales 1996). This pathway contains a meta- and an ortho-cleavage branch that
cleave the aromatic ring based on the functional groups present. To probe the co-metabolism of
glucose and phenol, we grew R. opacus with fully labeled glucose and unlabeled phenol. Fig. 3.6
shows high 12C abundance (~70%) in amino acids derived from the TCA cycle (such as Asp and
Glu), which confirms that R. opacus converts phenol into TCA cycle intermediates (acetyl-CoA
and succinyl-CoA) via the β-ketoadipate pathway (Fig. 3.3). During the co-utilization of
unlabeled phenol with

13

C-glucose, amino acids derived from the EMP, the ED, or the PP
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pathway also showed significant 12C abundance (25 to 50%), verifying that phenolic carbons can
percolate through the entire central metabolic network during glucose catabolism. Furthermore,
two different glucose concentrations (1 and 5 g/L) with the same phenol concentration (0.5 g/L)
were tested, but the 12C abundances in the resulting amino acids were almost identical. The lack
of inhibition on phenol utilization at higher glucose concentrations indicates that glucose does
not induce catabolite repression on phenol utilization.

Figure 3.6 The contribution of unlabeled phenol to synthesis of R. opacus proteinogenic
amino acids
White bar: 12C % abundance from two tracer experiments using 0.5 g/L of phenol with 1 g/L U13

C glucose. Black bar: 0.5 g/L of phenol with 5 g/L of U-13C glucose. The

12

C abundance of

amino acids derived from the TCA cycle suggests that much of the carbon from phenol enters the
TCA cycle (via the β-ketoadipate pathway). Significant

12

C % in amino acids derived from the

EMP, the ED, or the PP pathway suggests that carbon from phenol also entered gluconeogenesis.
The error bars represent standard deviations from GC-MS measurements (n = 2).
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Discussion
This study investigated R. opacus PD630, a promising host for lignocellulosic biomass
conversion. We discovered several interesting features of R. opacus PD630's metabolism. First,
R. opacus PD630 was found to have strong preference for the ED pathway. Many archaea use
the ED pathway, and a few Gram-negative bacteria have been reported to substitute the ED
pathway for EMP pathway mostly due to a lack of enzymes essential for EMP pathway. For
example, Roseobacter denitrificans does not have 6-phosphofructokinase and relies on the ED
pathway for glucose metabolism (Tang et al. 2009a). Previous

13

C-MFA studies on antibiotic-

producing actinomycete strains Nonomuraea sp. and Streptomyces tenebrarius also reported a
highly active ED pathway (Borodina et al. 2005; Gunnarsson et al. 2004). Although less ATPefficient, the ED pathway has no carbon loss and requires fewer enzymes for glucose catabolism,
which can increase metabolic flexibility and reduces the burden of synthesizing glycolysis
enzymes. The ED pathway was also proposed as a necessary trait for increased tolerance to
oxidative stress in environmental bacteria, such as soil bacteria (e.g., Pseudomonas) and marine
bacteria (e.g., Alphaproteobacteria) (Chavarría et al. 2013; Flamholz et al. 2013; Klingner et al.
2015). The ED pathway also generates NADPH, thus lowering the dependence on the PP
pathway for carbon oxidation and NADPH supply. The ED pathway is vital for accumulation of
intracellular storage compounds, such as poly-3-hydroxybutyrate in E. coli, because this pathway
increases the availability of acetyl-CoA and NADPH (Hong et al. 2003). Recent reports indicate
that engineering the ED pathway in E. coli can reduce metabolic burdens and improve cellular
NADPH/NADP+ ratio for chemical synthesis (Ng et al. 2015; Zhang et al. 2014).
We have found that R. opacus PD630 can operate an active glyoxylate shunt. We also
uncovered the activity of unannotated glycine dehydrogenase, which is present in related
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Mycobacterium and Rhodoccocus species (Feisthauer et al. 2008; Tang et al. 2009b). Moreover,
13

C-fingerprinting results suggest the anaplerotic reactions for CO2 fixation, cofactor balancing,

and metabolite synthesis in R. opacus PD630. Based on genome annotation, the enzymes
responsible

for

the

anaplerotic

pathways

are

the

malic

enzyme

(LPD02638),

phosphoenolpyruvate carboxylase (LPD01702), and pyruvate carboxylase (LPD01846). Our
RNA-seq data showed the high expression of these enzymes in R. opacus cultures with glucose
or phenol (unpublished results), confirming our finding by

13

C-fingerprinting. High fluxes

through anaplerotic pathways can increase R. opacus’ carbon and cofactor flexibility for
biosynthesis. For example, malic enzyme supports lipid accumulation as the pyruvate shunt
increases both NADPH and carbon availability for lipid synthesis (Zhang et al. 2007). PEP
carboxykinase would allow metabolites produced from phenol degradation to be converted into
gluconeogenesis intermediates, a key strategy for simultaneous use of phenol and glucose.
Carbon catabolite repression is an important factor for lignocellulosic biofuel production.
Because multiple forms of substrates are present in degradation mixtures of lignocellulosic
biomass, simultaneous utilization of carbon sources, such as glucose and aromatics, would
enable higher productivity. For many microbes, the carbon from secondary substrate may not
enter all central pathways during their co-metabolism. For example, Mortierella isabellina
simultaneously uptakes acetate and glucose, but the carbon from acetate is mainly assimilated
into lipid biosynthesis pathways and the TCA cycle rather than through gluconeogenesis (Ruan
et al. 2015). During co-utilization of glucose and phenol by R. opacus, metabolites from the
phenol degradation percolate through the entire metabolic network via both the TCA cycle and
gluconeogenesis. The two bottleneck steps in the EMP pathway are 6-phosphofructokinase (F6P
 FBP) and pyruvate kinase (PEP  PYR), both of which are inhibited by ATP and subsequent
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intermediate metabolites. In gluconeogenesis, two key enzymes, PEP carboxykinase (OAA 
PEP + CO2) and fructose-1,6-bisphosphatase (FBP  F6P), are used to reverse glycolysis flux
(Mathews et al. 2013). Usually, gluconeogenesis and the EMP pathway are reciprocally
regulated. In contrast, the ED pathway for glucose catabolism might be a distinctive strategy for
R. opacus to avoid such regulation, allowing phenol to be incorporated through the
gluconeogenesis pathway. The activity of the two non-competing pathways (the ED pathway for
sugar degradation and gluconeogenesis for the assimilation of degradation products from
aromatic compounds) can explain the absence of catabolite repression during phenol utilization
in Rhodococcus (Szőköl et al. 2014; Vesely et al. 2007). Interestingly, high fluxes through PEP
carboxykinase, fructose-1,6-bisphosphatase, and the ED pathway are also found in other
actinomycete bacteria(Borodina et al. 2005; Gunnarsson et al. 2004).
Recently, isotopic non-stationary

13

C-MFAs were developed(Antoniewicz 2015; Young

et al. 2011). These advanced MFA techniques reduce the duration of labeling experiments and
improve flux measurement quality. However, quantitative flux analysis is still expensive and
time-consuming (Supplementary Figure 3.1). Especially, training qualified 13C-MFA researchers
requires extensive practice in modeling, analytical chemistry, and microbiology. Therefore,
common microbiology laboratory cannot easily perform MFA without collaboration with a
professional

13

C-MFA group. Alternatively,

metabolite labeling resulting from various

13

13

C-fingerprinting only requires comparison of

C-cultures. Such qualitative metabolic analysis,

through measuring a small subset of key amino acids, reduces experimental steps, culture
volumes, data analysis, and model calculations. To assist labs unfamiliar with

13

C-pathway

tracing, we have designed a toolkit (Fig. 6). The prototype kit, similar to micro-cultivation

49

devices (Hermann et al. 2003), has an 8-well block that holds sterilized test tubes for parallel
labeling experiments.

Figure 3.7 A kit for 13C fingerprinting
The kit consists of an 8-well block, sterile tubes containing 25 mg of
gassing manifold. Microbes can be grown in different combinations of

13

13

C-substrates, and a

C-substrates, each of

which probes specific pathways as indicated. Custom choices of labeled substrates may target
novel pathways (such as Re-citrate synthase, citratemalate pathway, C1-metabolism, etc.) in
nonmodel species as described in our previous paper (Tang et al. 2012).
Each test tube contains a

13

C-tracer (~25 mg) or a mixture of

12

C- and

13

C-tracers to probe

targeted pathways. Since only proteinogenic amino acids are used for pathway analysis, a 4-6
mL culture volume is sufficient. A small culture volume reduces 13C-substrate costs and provides
good biomass growth (Supplementary Table 3.2). After cultures enter exponential phase, the
biomass can be harvested and hydrolyzed (note that the block of the kit can be used for drying
amino acid solutions). The manifold can also aerate the cultures during cultivation. With this kit,
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users do not need to order large amounts of expensive

13

C-substrates (standard tracers are often

sold by ~ grams per order). By using only necessary amounts of tracers, 13C-substrate cost can be
reduced. In addition, tracer experiments, labeling determination by GC-MS, and pathway
analysis can be completed on the timescale of three days.

3.3 Conclusion
The study of non-model species allows for the development of new microbial chassis for the
biosynthesis of useful products. As tolerance to and utilization of various carbon sources become
more important for profitability, searching for the ideal microbial host for biochemical
production becomes important. This study demonstrates that

13

C-fingerprinting can identify

interesting metabolic strategies of R. opacus for tolerating and utilizing toxic aromatic
compounds. Although 13C-fingerprinting and comparison of isotopic labeling from various tracer
experiments cannot draw quantitative metabolic conclusions, this approach provides a time- and
cost-efficient way to reveal active pathways. To make this approach widely adopted, we
developed a 13C-kit for studying diverse microbes with a previously published tutorial (You et al.
2012). This kit can expedite the design-build-test-learn cycle of metabolic engineering by
enabling rapid investigation of microbial cell factories. It may also probe many microbial
systems that are not amenable to rigorous

13

C-MFA.

13

C-fingerprinting provides a

complementary approach to 13C-MFA, which will be our next step for profiling metabolic fluxes
of R. opacus for co-utilization of both phenolic compounds and sugars.

3.4 Materials and Methods
3.4.1 Chemicals, strain, and growth conditions
13
C-labeled chemicals were from Cambridge Isotope Laboratories (Tewksbury, MA). All other
chemicals (glucose, glyoxylate, etc.) were purchased from Sigma Aldrich (St. Louis, MO).
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Rhodococcus opacus PD630 was grown in defined media at 30°C and 250 rpm using 50 mL
glass culture tubes. The minimal medium contained 1.0 g MgSO4·7H2O, 0.015 g CaCl2·2H2O,
1.0 mL trace element solution, 1.0 mL stock A solution, and 35.2 mL 1.0M phosphate buffer
(Chartrain et al. 1998). The trace element solution contained (per L) 0.5 g FeSO4·7H2O, 0.4 g
ZnSO4·7H2O, 0.02 g MnSO4·H2O, 0.015g H3BO3, 0.01 g NiCl2·6H2O, 0.25 g EDTA, 0.05 g
CoCl2·6H2O, and 0.005 g CuCl2·2H2O. The stock A solution contained (per L) 2 g
NaMoO4·2H2O and 5 g FeNa·EDTA. The phosphate buffer contained (per L) 113 g K2HPO4 and
47 g KH2PO4. (NH4)2SO4 was used as the nitrogen source (1 g/L). Culture media were filtersterilized using a 0.22 μm filter. For all cultures, a single colony from LB agar plates was grown
in 2 mL of the minimal medium with 5 g/L of glucose for 36-48 hours. This seed culture was
transferred into 10 mL of unlabeled medium and incubated for 24 hours. The second subculture
(OD600 ~1) was used as the inoculum for tracer experiments. Eight labeling experiments were
designed to probe targeted metabolic pathways in R. opacus, as shown in Table I. Each

13

C-

culture was inoculated at an initial OD600 of 0.01 (biological duplicate) in 5 mL culture volume.
Once cells reached mid-exponential phase, they were harvested (by centrifugation) for amino
acid extraction and gas chromatography-mass spectrometry (GC-MS) analysis.
3.4.2 Amino acid extraction and GC-MS analysis
Amino acid extraction and GC-MS analysis were performed as described previously (You et al.
2012a). In brief, cell pellets were washed with 0.9% (w/v) of NaCl solution, and then hydrolyzed
in 1.5 mL of 6M HCl at 100oC overnight. The resulting amino acids were air-dried, and then
derivatized by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide prior to GC-MS analysis.
The GC-MS condition was described in a previous protocol paper (You et al. 2012). For isotopic
tracing, we used the fragments [M-15]+ or [M-57]+ (containing the entire amino acid backbone),
[M-159]+ (containing the amino acid backbone after loss of its first carbon), and f(302)+
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(containing the first and second amino acid backbone). The labeling data (i.e., M0, M1, M2, etc.)
represent fractions of unlabeled, singly-labeled, and doubly-labeled metabolites, respectively.
The natural isotopic abundance of derivatized amino acids was corrected using a reported
algorithm (Wahl et al. 2004a).

12

C abundance in amino acids was calculated by the following

equation:
𝑛
12

𝐶 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = [∑
𝑖

(𝑛 − 𝑖)
∗ 𝑀𝑖 ]
𝑛

(1)

where n is the total number of carbons present in the amino acid, Mi is the intensity of the mass
isotopomer, and i represents the number of labeled carbons. In addition, by analyzing the mass
spectra of amino acid fragments, we can obtain individual isotopomer fractions for C2 (glycine)
and C3 (serine and alanine) amino acids. The isotopomer distribution allows for flux ratio
estimations (Klingner et al. 2015). Equations 2-4 roughly estimate the influence of the flux ratio
on the alanine isotopomer distribution:
𝐼100 =

𝐼000

𝑣𝐸𝐷
5
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 + 3 𝑣𝑃𝑃

5
𝑣𝑃𝑃 + 𝑣𝐸𝐷 + 𝑣𝐸𝑀𝑃
= 3
5
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 + 3 𝑣𝑃𝑃

𝐼001 =

(2)

(3)

𝑣𝐸𝑀𝑃
5
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 + 3 𝑣𝑃𝑃

(4)

where vED, vEMP, and vPP are the relative fluxes for the ED pathway, EMP pathway, and pentose
phosphate pathway, respectively. Ixxx is the fraction of the isotopomer, with 1 denoting the
carbon position of

13

C (e.g., I001 is the abundance of alanine labeled at carbon position 3). The

above equations were used to obtain the relative flux ratios among the ED pathway, EMP
pathway, and the pentose phosphate pathway. However, these equations assume that there is no
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reversibility of reactions or other influential pathways (Wiechert et al. 1997), representing an
approximate analysis of the three glucose catabolic pathways only towards pyruvate node.
3.4.3 Reverse Transcription PCR (RT-PCR)
The KEGG genome database suggests two putative glycine dehydrogenases (LPD04987 and
LPD07163) that may convert glyoxylate into glycine. To check their gene expression levels, RTPCR was performed. 50 mL cultures (with 5 g/L glucose and 0.5 g/L glyoxylate) were grown in
250 mL baffled flasks to exponential phase and harvested (OD600 ~1) by centrifugation at 4600 g
for 15 minutes. RNA isolation was performed as described previously with some modifications
(Hoynes-O'Connor et al. 2015). More details on the RNA extraction and cDNA synthesis can be
found in the Supplementary Materials. Briefly, RNA was extracted using TRIzol reagent (Life
Technologies, CA) followed by DNase I treatment using the DNA-free DNA Removal Kit (Life
Technologies, CA). cDNA was prepared using the AffinityScript QPCR cDNA Synthesis Kit
(Agilent Technologies, CA). The cDNA from biological duplicates was run in technical triplicate
to confirm the expression of each gene. One reference gene encoding a putative DNA
polymerase IV (LPD05856) was used as a positive control. A closely-related homologue of
LPD05856, ro01702 (>95% sequence similarity), was stably expressed in a variety of conditions
in a similar strain, Rhodococcus jostii RHA1 (Gonçalves et al. 2006; LeBlanc et al. 2008).
Primers were either chosen from previous literature or designed using NCBI Primer-BLAST
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
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3.5 Supplementary Materials for Chapter 3

1
2
3
4
5
6
7
8
9
10

Estimated itemized costs are listed as follows:
Student training (cost includes “student stipends”) and preliminary studies (*)
Labor costs for 13C-culture and metabolite labeling analysis
Labor costs for MFA modeling and flux calculation
13
C-substrate and medium cost
Substrate/metabolite concentration analysis (using R-Biopharm Enzyme kits)
GC-MS user fee for isotopomer analysis
Lab supplies (tubes, cuvettes, pipettes, vials, etc.)
Other cost (e.g., chemicals, software, dry ice, etc.)
Post-13C-MFA (check plausibility of MFA results via additional experiments)
Result summary and paper drafting (labor costs included)

* preliminary studies include: a) finding a defined minimal medium for cell culture, b)
determining whether the biomass growth can reach a steady state, c) analyzing biomass
composition (protein, lipid, carbohydrate, RNA, and DNA content), and d) assessing whether the
cell metabolic network is correctly determined (i.e., are there any mis-annotations?).
Total cost = $185,000 (include overhead cost and training of 13C-MFAers);
Direct cost = ~$85,000 (items 2~9).
Project period: July 2012~ August 2013
Figure S1: Budgets for a 13C-MFA project (Synechocystis 6803 flux analysis) in the Tang
Lab (You et al., 2014). Quantitative determination of proper flux values in a metabolic network
is expensive and time-consuming for new users.
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Reference: You L, Berla B, He L, Pakrasi HB, Tang YJ. 13C-MFA Delineates the
Photomixotrophic Metabolism of Synechocystis sp. PCC 6803 under Light and Carbon Sufficient
Conditions. Biotechnology Journal. 2014. 9:5.

A

B

C

Figure S2. Images of multiple functions of the

13

C-Fingerprinting Kit. A. Gassing manifold

for CO2 supply into cyanobacterial cultures. B. Tube cultures on a shaker. C. The kit block can
be used to hold GC vials for air-drying the solutions of hydrolyzed amino acid.
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Table S1.1 Mass Isotopomer Distribution (MID) of Alanine and Serine in 1-13C glucose tracer
experiment (Standard deviation is from two biological duplicates). The MID data revealed a
highly active ED pathway (See Figure 2).
Alanine

[M-57]+

[M-159]+

f(302)+

Serine

M0
M1
M2

0.52±0.04
0.47±0.04
0.01±0.01

0.95±0.05
0.04±0.05
0.01±0.01

0.51±0.05
0.48±0.05
0.00±0.01

M0
M1
M2

[M-57]+ [M-159]+

f(302)+

0.96±0.03 0.98±0.02 0.96±0.03
0.04±0.02 0.02±0.01 0.02±0.02
0
0
0

Note: for TBDMS samples, f(302)+ often has high signal-to-noise ratio. But this peak can be still
used for qualitative validation of carbon labeling positions in amino acids.

Table S2.2 Growth rate comparison between cultures grown in 50 mL shake tubes versus in our
13

C-fingerprinting kit on the same shaker (200 rpm). The culture medium for E.coli is 2%

glucose M9 medium, while R. opacus culture used the minimal medium with 5 g/L glucose as
described in the section of Materials and Methods.

Table S3.3. Primers used for RT-PCR in this study.

Primer

Sequence (5’ to 3’)

LPD05856 F

GCTTCTTCGCTGTCTTCTTGC

LPD05856 R

CGACAACAAGTTACGAGCCA

LPD07163 F

CGGTCTGCGATCTGGTTCAC

LPD07163 R

CTTGTGCAGGTTCAGGTGTG

LPD04987 F

CCTGTGCGGTGCAGATGTTC

LPD04987 R

CCAAGCACGCACGTCAACTC
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Protocols for RT-PCR
RNA Extraction
50 mL of cell culture was grown in a 250 mL baffled flask to exponential phase and harvested
(OD600 ~1) by centrifugation at 4600g for 15 minutes. The supernatant was discarded, and the
cell pellet was resuspended in 1 mL TRIzol reagent (Life Technologies) and stored at -80°C until
later use. Within one week, the sample was thawed to room temperature followed by incubation
at 95°C for 5 minutes and then placed on ice for 5 minutes. After the addition of chloroform,
samples were centrifuged at 12,000g for 15 minutes at 4°C. The upper aqueous phase was
removed and resuspended in 100% isopropanol, then centrifuged at 12,000g for 30 minutes at
4°C to pellet the RNA. The supernatant was discarded and the RNA pellet was washed with 1
mL of ice cold ethanol and centrifuged at 8000g for 5 minutes at 4°C. The RNA pellet was air
dried and resuspended in DEPC-treated water. At this step, RNA concentrations ranged from
1000-5000 ng/μL and A260/A280 values ranged from 1.81-2.05. RNA and DNA concentrations
were routinely measured at intermediate steps using a NanoDrop 2000c UV-Vis
spectrophotometer (Thermo Scientific).
DNase Treatment & RNA Purification
For DNase treatment, the isolated RNA was treated using the DNA-free DNase Kit (Life
Technologies, CA). For each sample, 10 μg of RNA was added to a total volume of 50 μL
containing 5 μL of DNase I Buffer and 2 μL of DNase I. Samples were incubated at 37°C for 30
minutes, then inactivated by adding 10 μL of the DNase Inactivation reagent and briefly
vortexing. Samples were then incubated for 2 minutes at room temperature, followed by
centrifugation at 10,000g for 90 seconds. The supernatant containing the RNA was transferred to
a new tube and stored at -80°C. After DNase treatment, RNA concentrations ranged from 50-175
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ng/μL with A260/A280 ratios of 1.72-1.90. Samples were checked for DNA contamination using
PCR (see below for conditions), and no samples contained bands after DNase treatment. To
ensure that there were no other contaminants for cDNA synthesis, samples were purified using
the RNA Clean & Concentrator-5 Kit (Zymo Research) following the kit’s instructions.
cDNA Synthesis & PCR
All primers were ordered from Integrated DNA Technologies and their sequences can be found
in Supplementary Table S3. cDNA synthesis was performed using the AffinityScript QPCR
cDNA Synthesis Kit following the kit’s instructions. Each sample contained approximately 500
ng of purified RNA in a 20 μL reaction volume containing 10 μL of cDNA synthesis master mix,
3 μL of random primers, and 1 μL of Affinity Script RT/RNase Block enzyme mixture. All
samples were run with the following program: 25°C for 5 minutes, 42°C for 15 minutes, and
95°C for 5 minutes. PCR was performed using GoTag DNA polymerase (Promega Corporation)
under the following thermocycler conditions: 95°C for 2 minutes, followed by 40 cycles of 95°C
for 45 seconds, 60°C for 45 seconds, and 20 seconds at 72°C. After 40 cycles, samples were run
at 72°C for 5 minutes. Gel electrophoresis to confirm band sizes was performed using a 2%
agarose gel with SYBR-Safe DNA Gel stain (Life Technologies). PCR without template was
performed to confirm that no other bands were formed by primers.
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Supplemental Isotopomer Data Tables (Raw GC-MS data)
Mass Spectrum (MS) data from analyzed amino acids in the 13C-Fingerprinting Experiments.
Abbreviations used: Ala, Alanine; Gly, Glycine; Val, Valine; Leu, Leucine; Ile, Isoleucine; Ser,
Serine; Thr, Threonine; Phe, Phenylalanine; Asp, Aspartate; Glu, Glutamate; His, Histidine; Tyr,
Tyrosine and Mass Isotopomer Distribution (MID). In general, standard errors of amino acid
labeling analysis using TBDMS method are within 0.02.

Amino TBDMS
Acid Fragment
[M-57]+
[M-159]+
Ala
f(302)+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
f(302)+
[M-57]+
Thr
[M-85]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
His
[M-159]+
[M-57]+
Tyr
[M-159]+

M0 M1
0.52 0.47
0.95 0.04
0.51 0.48
0.96 0.04
0.97 0.03
0.46 0.52
0.94 0.04
0.92 0.07
0.75 0.21
0.64 0.30
0.74 0.24
0.96 0.04
0.99 0.01
0.96 0.02
0.66 0.28
0.76 0.24
0.87 0.12
0.90 0.09
0.67 0.28
0.77 0.22
0.62 0.36
0.93 0.07
0.69 0.29
0.68 0.29
0.86 0.13
0.90 0.08

1-13C Glucose
MID
M2
M3
M4
M5
0.01 0.00
0.01
0.00
0.00
0.01
0.00
0.01
0.04
0.06
0.02
0.00
0.00
0.00
0.05
0.00
0.01
0.01
0.05
0.00
0.03
0.00
0.02
0.01
0.01
0.01

0.00
0.01
0.00
0.00
0.00
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.01
0.00
0.00

0.00
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M6

M7

M8

M9

0.00
0.00

0.00
0.00

0.00

0.00
0.00
0.00
0.00
0.00

0.00

0.00
0.00
0.00

0.00
0.00

0.00
0.00

0.00
0.00
0.00
0.00
0.00
0.00

0.00

Note: High standard deviation

0.00
0.00
0.00
0.00

0.00

0.00

0.00
0.00

0.00
0.00

0.00
0.00

0.00

C
%
83.6
97.0
75.0
97.9
97.0
89.1
97.5
98.6
94.3
92.9
94.5
99.1
99.5
97.0
90.3
92.2
98.1
98.3
90.6
91.7
92.5
98.2
95.4
94.1
97.9
97.6

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-85]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
His
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.01
0.01
0.08
0.10
0.01
0.01
0.00
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.00
0.00
0.01
0.01
0.01
0.00

U-13C6 Glucose + Glyoxylate
MID
M1
M2
M3
M4
M5
0.01 0.04 0.95
0.04 0.95
0.03 0.89
0.90
0.00 0.00 0.01 0.06 0.93
0.00 0.01 0.06 0.92
0.00 0.04 0.13 0.03 0.12
0.00 0.00 0.01 0.07 0.91
0.00 0.02 0.08 0.05 0.18
0.00 0.01 0.03 0.19 0.77
0.02 0.04 0.94
0.04 0.95
0.01 0.03 0.15 0.79
0.02 0.16 0.80
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.05 0.15 0.80
0.02 0.16 0.81
0.00 0.00 0.03 0.17 0.80
0.00 0.02 0.09 0.88
0.00 0.01 0.00 0.01 0.06
0.00 0.00 0.03 0.06 0.91
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
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M6

M7

M8

M9

0.01
0.09

0.09
0.90

0.89

0.02
0.10

0.10
0.86

0.88

0.68
0.66

0.00
0.01

0.90
0.00
0.02

C
%
2.5
3.1
9.7
9.8
2.3
2.6
12.7
2.5
11.0
6.0
3.0
3.3
7.5
8.1
2.3
2.1
6.9
7.5
5.2
3.8
3.1
3.1
2.6
3.1

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-85]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
His
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.21
0.23
0.57
0.60
0.09
0.10
0.02
0.06
0.05
0.07
0.44
0.47
0.11
0.13
0.33
0.34
0.10
0.14
0.04
0.05
0.15
0.15
0.34
0.35

U-13C2 Acetate + Glyoxylate
MID
M1
M2
M3
M4
M5
M6
0.05 0.32 0.42
0.32 0.44
0.06 0.38
0.40
0.13 0.15 0.19 0.09 0.35
0.25 0.20 0.09 0.36
0.09 0.17 0.21 0.11 0.10 0.30
0.19 0.22 0.11 0.08 0.34
0.14 0.16 0.16 0.11 0.10 0.27
0.18 0.21 0.14 0.10 0.30
0.07 0.07 0.42
0.11 0.42
0.13 0.18 0.17 0.41
0.22 0.19 0.46
0.11 0.06 0.03 0.01 0.02 0.02
0.13 0.05 0.02 0.02 0.02 0.03
0.13 0.16 0.14 0.46
0.20 0.18 0.49
0.09 0.15 0.15 0.13 0.45
0.12 0.16 0.16 0.51
0.24 0.17 0.03 0.04 0.13 0.25
0.23 0.18 0.06 0.12 0.25
0.13 0.06 0.03 0.01 0.02 0.02
0.14 0.05 0.02 0.02 0.02 0.03

62

12

M7

M8

M9

0.03
0.09

0.10
0.30

0.29

0.03
0.09

0.09
0.28

0.27

C
%
35.1
39.7
59.7
60.2
37.9
40.8
37.1
40.1
41.3
41.3
50.7
52.7
34.2
34.0
53.5
53.9
31.7
32.7
28.1
26.2
51.0
49.5
55.8
55.8

Amino TBDMS
Acid Fragment M0
[M-57]+
0.40
Ala
+
[M-57]
0.42
Gly
+
[M-85]
0.99
+
[M-57]
0.39
Val
[M-159]+
0.94
+
[M-15]
0.07
Leu
+
[M-159]
0.92
+
[M-15]
0.09
Ile
[M-159]+ 0.38
[M-57]+
0.41
Ser
]+
[M-159
0.99
+
[M-57]
0.08
Thr
[M-85]+
0.35
+
[M-57]
0.11
Asp
]+
[M-159
0.40
+
[M-57]
0.08
Glu
[M-159]+
0.17
+
[M-57]
0.27
His
[M-159]+
0.26
+
[M-57]
0.09
Tyr
]+
[M-159
0.20

1-13C Acetate
MID
M1
M2
M3
M4
M5
0.59 0.01 0.00
0.59 0.00
0.01
0.59 0.01 0.00 0.00 0.00
0.04 0.01 0.02 0.00
0.70 0.07 0.15 0.02 0.00
0.06 0.01 0.01 0.00 0.00
0.51 0.33 0.05 0.01 0.01
0.58 0.03 0.00 0.00 0.00
0.59 0.00 0.00
0.01 0.00
0.60 0.32 0.00 0.00
0.65 0.01 0.00
0.61 0.28 0.00 0.00
0.59 0.00 0.00
0.46 0.36 0.09 0.01 0.00
0.76 0.06 0.01 0.00
0.50 0.20 0.04 0.00 0.00
0.49 0.20 0.04 0.00 0.00
0.31 0.41 0.19 0.01 0.00
0.47 0.29 0.02 0.00 0.00
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M6

M7

M8

M9

0.00
0.00

0.00
0.00

0.00

0.00
0.00

0.00
0.00
0.00

C
%
79.6
70.8
99.3
87.4
97.3
77.3
97.4
76.9
86.9
80.4
99.7
69.1
78.9
71.1
79.9
70.6
77.8
83.1
86.9
81.0
76.7

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-85]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.01
0.01
0.01
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00

U-13C6 Glucose + Bicarbonate
MID
M1
M2
M3
M4
M5
M6
0.00 0.03 0.96
0.04 0.95
0.03 0.97
0.98
0.00 0.00 0.00 0.05 0.95
0.00 0.01 0.05 0.94
0.00 0.01 0.03 0.02 0.12 0.83
0.00 0.00 0.01 0.06 0.93
0.00 0.01 0.02 0.02 0.16 0.80
0.00 0.00 0.01 0.12 0.86
0.00 0.03 0.96
0.02 0.96
0.00 0.01 0.11 0.87
0.01 0.10 0.89
0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.01
0.00 0.01 0.11 0.87
0.01 0.10 0.88
0.00 0.00 0.01 0.12 0.86
0.00 0.01 0.04 0.94
0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.02
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12

M7

M8

M9

0.01
0.07

0.07
0.92

0.91

0.01
0.07

0.07
0.90

0.91

C
%
1.9
3.1
2.1
2.2
1.6
2.0
4.6
2.1
4.9
3.4
1.7
2.4
4.2
4.5
1.6
1.6
4.1
4.5
3.4
2.1
1.6
2.1

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-159]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
His
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.15
0.17
0.15
0.17
0.10
0.10
0.10
0.12
0.12
0.14
0.11
0.12
0.22
0.21
0.02
0.02
0.24
0.25
0.11
0.10
0.02
0.02
0.02
0.02

U-13C6 Glucose + Malate
MID
M1
M2
M3
M4
M5
0.02 0.04 0.79
0.05 0.77
0.04 0.81
0.83
0.02 0.04 0.05 0.06 0.73
0.02 0.08 0.07 0.73
0.02 0.06 0.07 0.08 0.11
0.04 0.05 0.06 0.10 0.62
0.02 0.12 0.07 0.06 0.14
0.03 0.11 0.05 0.14 0.53
0.03 0.05 0.81
0.06 0.82
0.03 0.05 0.12 0.58
0.04 0.15 0.60
0.03 0.01 0.02 0.06 0.02
0.04 0.01 0.02 0.06 0.02
0.03 0.05 0.13 0.56
0.05 0.13 0.57
0.02 0.10 0.06 0.16 0.55
0.02 0.11 0.09 0.67
0.01 0.04 0.03 0.02 0.14
0.06 0.05 0.04 0.14 0.75
0.04 0.01 0.02 0.07 0.02
0.04 0.01 0.02 0.07 0.03
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12

M6

M7

M8

M9

0.05
0.09

0.08
0.67

0.67

0.04
0.08

0.08
0.65

0.66

0.56
0.47

0.05
0.08

0.75
0.05
0.08

C
%
17.5
19.9
17.1
17.3
17.4
17.5
24.3
23.6
29.6
28.3
14.8
15.4
29.4
28.8
14.3
14.0
31.4
32.8
24.3
20.0
9.4
13.3
14.9
15.0

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-159]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
His
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.25
0.26
0.24
0.25
0.33
0.33
0.42
0.54
0.50
0.61
0.13
0.14
0.27
0.27
0.61
0.61
0.06
0.06
0.05
0.05
0.10
0.12
0.34
0.34

U-13C6 Glucose + Yeast Extract
MID
M1
M2
M3
M4
M5
M6
0.01 0.03 0.71
0.04 0.71
0.03 0.73
0.75
0.02 0.01 0.02 0.04 0.58
0.02 0.03 0.05 0.57
0.03 0.09 0.16 0.04 0.05 0.23
0.08 0.01 0.02 0.03 0.32
0.03 0.11 0.14 0.02 0.05 0.15
0.04 0.11 0.02 0.04 0.18
0.03 0.05 0.79
0.07 0.79
0.02 0.02 0.12 0.56
0.04 0.12 0.58
0.05 0.00 0.00 0.00 0.00 0.01
0.05 0.01 0.00 0.00 0.00 0.01
0.01 0.03 0.15 0.74
0.03 0.15 0.76
0.01 0.03 0.05 0.17 0.69
0.01 0.06 0.08 0.81
0.01 0.01 0.01 0.02 0.18 0.67
0.00 0.01 0.04 0.17 0.67
0.03 0.00 0.00 0.00 0.00 0.02
0.03 0.01 0.00 0.01 0.01 0.03
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M7

M8

M9

0.01
0.03

0.03
0.29

0.29

0.02
0.05

0.06
0.53

0.53

C
%
26.5
27.6
25.2
25.0
37.3
37.1
59.5
62.6
68.1
72.1
16.8
17.4
33.0
33.1
66.0
66.7
12.3
13.2
13.4
10.5
15.4
17.1
38.6
38.8

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-159]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.24
0.26
0.30
0.33
0.08
0.08
0.05
0.06
0.14
0.15
0.19
0.23
0.47
0.52
0.01
0.01
0.49
0.53
0.27
0.29
0.01
0.01

U-13C6 Glucose (5 g/L) + Phenol (0.5 g/L)
MID
M1
M2
M3
M4
M5
M6
0.08 0.08 0.60
0.13 0.61
0.07 0.63
0.67
0.06 0.16 0.19 0.12 0.39
0.07 0.30 0.16 0.39
0.05 0.20 0.19 0.28 0.09 0.14
0.07 0.22 0.20 0.27 0.19
0.10 0.33 0.18 0.11 0.10 0.05
0.11 0.38 0.16 0.14 0.06
0.11 0.11 0.59
0.18 0.58
0.15 0.17 0.13 0.08
0.21 0.19 0.09
0.01 0.01 0.02 0.12 0.10 0.19
0.01 0.01 0.04 0.13 0.12 0.29
0.14 0.17 0.12 0.08
0.19 0.19 0.10
0.12 0.25 0.12 0.13 0.12
0.15 0.25 0.12 0.19
0.01 0.01 0.03 0.12 0.10 0.18
0.01 0.02 0.04 0.14 0.12 0.28
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M7

M8

M9

0.18
0.14

0.11
0.24

0.24

0.19
0.14

0.12
0.24

0.24

C
%
32.2
32.4
33.4
33.3
32.5
32.5
42.6
37.7
58.4
55.7
30.0
32.5
70.6
71.8
27.2
25.3
71.0
71.3
58.3
55.7
27.3
25.8

Amino TBDMS
Acid Fragment
[M-57]+
Ala
[M-159]+
[M-57]+
Gly
[M-85]+
[M-57]+
Val
[M-159]+
[M-15]+
Leu
[M-159]+
[M-15]+
Ile
[M-159]+
[M-57]+
Ser
[M-159]+
[M-57]+
Thr
[M-159]+
[M-57]+
Phe
[M-159]+
[M-57]+
Asp
[M-159]+
[M-57]+
Glu
[M-159]+
[M-57]+
Tyr
[M-159]+

M0
0.21
0.23
0.28
0.30
0.05
0.06
0.03
0.04
0.09
0.11
0.18
0.22
0.45
0.47
0.01
0.01
0.45
0.50
0.28
0.29
0.01
0.01

U-13C6 Glucose (1 g/L) + Phenol (0.5 g/L)
MID
M1
M2
M3
M4
M5
M6
0.08 0.08 0.63
0.13 0.64
0.07 0.65
0.70
0.05 0.16 0.19 0.13 0.41
0.06 0.29 0.17 0.41
0.03 0.16 0.27 0.29 0.09 0.12
0.05 0.19 0.22 0.30 0.20
0.08 0.31 0.27 0.14 0.08 0.04
0.11 0.38 0.18 0.16 0.07
0.10 0.12 0.60
0.16 0.62
0.11 0.23 0.16 0.05
0.26 0.19 0.08
0.01 0.01 0.02 0.08 0.10 0.19
0.01 0.01 0.03 0.10 0.11 0.29
0.15 0.19 0.14 0.08
0.20 0.21 0.09
0.15 0.30 0.14 0.09 0.04
0.18 0.32 0.13 0.07
0.01 0.01 0.02 0.09 0.11 0.19
0.01 0.01 0.04 0.11 0.13 0.26

68

12

M7

M8

M9

0.20
0.17

0.13
0.27

0.26

0.18
0.18

0.13
0.25

0.25

C
%
29.1
29.5
31.2
30.2
29.1
29.5
41.6
34.1
55.1
52.7
28.5
30.0
68.5
71.0
24.4
23.5
69.1
70.3
65.0
62.1
25.2
24.7

4 Chapter Four: Characterizing and Re-wiring of Metabolic
Pathways in Cyanobacteria
The work presented has been partially reported in the following publications:
Abernathy, M.H., Yu, J., Ma, F., Liberton, M., Ungerer, J., Hollinshead, W., Gopalakrishnan, S., He, L.,
Maranas, C., Pakrasi, H.B., Allen, D.K., & Tang, Y.J. Deciphering phenotypes for fast photoautotrophic
growth in Synechococcus elongatus UTEX 2973.[Submitted] (I contributed to the transient 13C-labeling
experiments ).
Wan, N., DeLorenzo, D.M., He, L., You, L., Immethun, C., Wang, G., Baidoo, E.E.K., Hollinshead,
W.D., Keasling, J.D., Moon, T.S., & Tang, Y.J. Cyanobacterial carbon metabolism: fluxome plasticity
and oxygen dependence. [Submitted] (I contributed to 13C-labeling experiments on Synechocystis 6803
and its EDP mutants).

Abstract
While Synechococcus elongatus UTEX 2973 and Synechococcus elongatus 7942 have a 99.8%
genetic similarity, they have significantly different growth rates at optimal conditions. The
fluxome of the faster-growing cyanobacterium, Synechococcus elongatus UTEX 2973, and its
close relative, Synechococcus elongatus 7942, were elucidated through isotopically nonstationary

13

C-Metabolic Flux Analysis.

The results showed higher flux through carbon

assimilatory and photorespiratory pathways were highlighted in S. elongatus 2973 as compared
to S. elongatus 7942. In addition, the resulting flux map revealed key metabolic differences
between these strains and model cyanobacterium, Synechocystis PCC 6803, which suggested a
novel metabolic engineering strategy for improved growth. The engineering strategy was to
replace the carbon inefficient pathways with a heterologous Entner-Doudoroff (ED) pathway in
Synechocystis 6803. However, the engineered strains failed to show improvements in growth or
enhanced activity of EDP under dark conditions. These results confirm that Synechocystis. 6803
oxidative pentose phosphate pathway and its other carbon-regenerating pathways are robust and
important for the strain’s growth.
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4.1 Introduction
The main roadblocks preventing cyanobacteria’s ability to compete with other microbial
platforms is its slow growth and heavy dependence on light acquisition. A novel cyanobacterium,
S. elongatus 2973, has been isolated with doubling times as high as 1.9 hours, growing as fast as
the industrial host, Saccharomyces cerevisiae (Yu et al. 2015). This new strain has the possibility
to alleviate the problems associated with cyanobacteria fermentation. In comparison to
Saccharomyces cerevisiae, cyanobacteria offer many advantages beneficial for advanced biofuel
production. They are robust, require minimal nutrients, and capable of CO2 fixation (Yu et al.
2013). Therefore, S. elongatus 2973 is a very promising cyanobacterial chassis for improving
cyanobacterial biofuel production. To further understand the metabolic phenotype behind its fast
growth, we conducted isotopically non-stationary 13C-Metabolic Flux Analysis (13C-MFA).
Unlike most heterotrophic metabolisms, which can form unique isotope distributions based
on their flux profile,

13

C-MFA on autotrophic (C1) metabolism requires measuring the rate of

isotopic enrichment to delineate the fluxes of the central metabolism (Nöh et al. 2007; Young et
al. 2011). Currently, only model cyanobacterium’s, Synechocystis PCC 6803, flux map has been
elucidated (Xiong et al. 2015; Young et al. 2011). These studies have identified a relatively
powerful oxidative pentose phosphate pathway (OPPP) under heterotrophic conditions (You et al.
2014), which is surprisingly still active ( ~15%) during autotrophic growth. In addition, the malic
enzyme had small but significant flux and was an important source of pyruvate for the cell
(Young et al. 2011). These features were prominent differences between S. elongatus 2973 and
Synechocystis 6803 autotrophic metabolisms. Thus, we re-wired Synechocystis 6803 metabolism
to use Entner-Doudoroff pathway (EDP) as a direct source of pyruvate and an alternative
pathway to the inefficient OPPP.
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4.2 Results and Discussion
4.2.1

13

C-MFA of 2973
S. elongatus 2973 and S. elongatus 7942 were both grown in a high-light photobioreactor

to early exponential phase, and then pulsed with NaH13CO2. The rate of labeling in the
metabolites was measured by quenching (a rapid halting of the metabolism) of the culture to
capture the labeling distribution at specific time points. Initially, we followed the traditional
method of quenching the metabolites with cold methanol then extracting using a methanolchloroform protocol. As methanol can be cooled to -70OC, it works well to rapidly cool the
culture. However, methanol is also the extraction solvent, and often the methanol quenching
solution will cause significant metabolite leakage.
Thus, we developed a quenching method using liquid nitrogen as the coolant that allowed
cultures to quickly drop to low temperatures (~ 4OC) without loss of metabolites. The method
consists of using a small canister that allows your culture tube to sit in liquid nitrogen while
constantly agitating the culture to prevent freezing. Use of a thermometer to measure the
temperature change showed that this method can rapidly cooled cultures. This provided us with
much better LC-MS data, allowing us to capture the labeling dynamics of key metabolites. The
publically available INCA software was used to generate the flux map shown in Figure
4.1(Young 2014).
While the overall CO2 uptake between the two Synechococcus strains gave different
absolute fluxes (not shown), once normalized, a clear view of the differences in metabolic
topology between the two strains are shown. S. elongatus 2973 has higher relative flux through
fructose-biphosphate aldolase (FBP->F6P) while S. elongatus 7942 has higher fluxes through
transketolase reactions. Interestingly, S. elongatus 2973 showed no flux through the malic
enzyme while S. elongatus 7942 maintained a small flux. In addition, the decreased flux towards
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G6P from F6P agrees with the lower demand of glycogen in the faster growing cyanobacterium
(Yu et al. 2015). The major flux differences between these optimal cyanobacterial metabolisms
and the previously reported flux distribution of Synechocystis 6803 were in the removal of CO2
draining reactions: malic enzyme and 6-phosphogluconate dehydrogenase. These variances,
while important for Synechocystis 6803 capacity to grow in various light and dark conditions,
may be limiting its optimal growth rate.
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Figure 4.1 Synechococcus elongatus 2973 Flux Map
Normalized (to net uptake of 100 mol CO2). Fluxes on the top are from S. elongatus 2973 and
fluxes on the bottom are produced from S. elongatus 7942. Dotted lines represented pathways
with enzymes that are not annotated for Synechococcus elongatus on the KEGG Genome
database. Abernathy et al., Manuscript Submitted

73

4.2.2 Reprogramming Synechocystis PCC 6803
While the growth rate of Synechocystis 6803 cannot compete with either S. elongatus
2973 or S. elongatus 7942, the strain is still favorable due to its excellent photomixotrophic
capabilities. Industrial cyanobacterial bioprocesses benefit from microbial hosts that can utilize
light and CO2 when sufficiently available and glucose under low light and CO2 conditions,
typical of environments in large photobioreactors or sun-lit reactors. Thus, the lack of flux
through OPPP and malic enzyme in S. elongatus 2973 suggested that these may be beneficial
targets for engineering Syn. 6803 to be a faster-growing photomixotrophic strain. As an
alternative to the OPPP, EDP is a glycolytic pathway that would (1) provide NADPH without
generating CO2, (2) provide pyruvate (and one glyceraldehyde 3-phosphate) which would reduce
the need for the malic enzyme and (3) only require two additional enzymes: 6PG dehydratase
(edd) and 2-keto-3-deoxyphosphogluconate (KDPG) aldolase (eda), to complete the pathway.
Heterologous pathways (edd and eda) from R. opacus PD630 and E. coli were introduced into
6803 via a replicative plasmid (RSF1010 replicon). Two promoters were used: the arabinoseinducing pBAD promoter and constitutive pTrc promoter.
Despite verification by RT-PCR, the engineered strains failed to show EDP activity using
our 1-13C glucose fingerprinting assay. For the EDP assay, the cells were grown under lightactivated dark conditions with 1-13C glucose and the resulting labeling distribution of alanine
(pyruvate-derived) were measured. If EDP is active then the m+0 of the [M-85]+ fragment would
be higher than the m+0 of the [M-57]+ fragment. As shown in Table 4.1, there is little to no
differences between the two fragments suggesting that glucose is almost exclusively being
degraded by OPPP in the dark condition.
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Table 4.1 Mass Isotopomer Distribution of Alanine (Pyruvate-derived) for Engineered
Strains
6803

pBAD-ED(roa) pTrc-ED(eco)

Δgnd*

Alanine
m-57
m+0
m+1

0.96
0.04

0.96
0.04

0.95
0.05

0.98
0.02

m+2
m+3

0.00
0.00

0.00
0.00

0.00
0.00

0.00
0.00

m-85
0.97
0.98
0.95
0.98
m+0
0.03
0.02
0.05
0.02
m+1
0.00
0.00
0.00
0.00
m+2
Technical standard deviation is 0.02.
* Δgnd did not grow under the dark conditions, thus the biomass is almost fully unlabeled.
*Residual 12C from NaHCO3 and glucose from the seed cultures may have minor influences on
distribution and thus this is only a qualitative assay on presence of EDP.
A previous study of the photoheterotrophic fluxome of 6803 has already revealed OPPP as
the major catabolic pathway for glucose (You et al. 2015). It is possible that the native
infrastructure of OPPP in 6803 cells is so robust that the engineered EDP could not compete.
Therefore, we disrupted OPPP by removing gnd from the genome and overexpressed EDP, this
strain showed significantly impaired growth under dark conditions, and thus we were unable to
get reliable data on EDP activity (Table 4.1 & Fig. 4.2).
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Figure 4.2 Growth Profile of ED-expressing (from R. opacus) 6803 strains
However, when the strains were supplied with ~50 μE/m2/s for photomixotrophic growth,
the over-expression of ED pathway in Δgnd strains improved growth compared to their wild type
counterparts (WT with ED plasmid) (Table 4.2).

Unfortunately, while 1-13C glucose

fingerprinting is an accurate tool when 6803 is forced to exclusively used their heterotrophic
metabolism, under light conditions the qualitative assay would fail to provide useful data due to
the uptake of CO2 and carbon re-cycling through the calvin cycle. Therefore, it is unclear if EDP
is active under photomixotrophic conditions, but gnd deletion does appear to recover the cell’s
growth from any metabolic burden effects.
Table 4.2 Engineered strains growth rates under light and dark conditions
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In addition, the knockout of gnd in 6803 resulted in an altered color of the supernatant. The
dark brown color was consistently produced in both strains with only gnd deletion and Δgnd
strains overexpressing the ED pathway. It is suspected the knockout would cause possible
accumulation of 6PG and reduced NADPH supply under dark conditions; it appears that this may
have a global effect on the cell metabolism. Suspecting that the color was due to a build-up of
pterine compounds, we added sodium diothionite, which would break the aromatic core and
result in a color change. Figure 4.3 shows our confirmation via a sodium diothionite treatment,
that the Δgnd strains secrete pterine-like compounds.

Figure 4.3 ∆gnd supernatant.
A) Supernatant from wild type (left) and ∆gnd (right) strains after 7 days of growth at ~100
µE/m 2 /s. ∆gnd produces a compound(s) that darkens the supernatant to a reddish-brown color.
To test whether the compound may be a class of pterine molecule, the sodium diothionite was
added(thought to cause a reduction/possible removal of the pterine’s aromatic core and evidence
by a color change). B) Untreated supernatant from ∆gnd (left) and ∆gnd supernatant treated with
sodium dithionite (right). Wan et al., Unpublished
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4.3 Conclusion and Future Work
Currently, Synechococcus elongatus 2973 is the fastest-growing cyanobacterium reported,
its flux map presents a topology that is optimized for autotrophic growth. Major differences
between the strain flux distribution and flux maps previously reported for Synechocystis 6803
sparked a novel engineering strategy to introduce a working Entner-Doudoroff pathway to
reduce fluxes through the oxidative pentose pathway and malic enzyme. However, our study
confirmed that heterologous expression of pathways may fail in Synechocystis 6803, possibly
due to misfolding, photosynthesis-dependence or other unknown problems.
Despite the confirmation of RNA production of the EDP enzymes, our assay failed to
detect significant EDP flux and the overexpression appeared to inhibit its growth in gnd
knockouts. With the lack of clear results on EDP activity in cyanobacteria, there is still interest in
reviewing whether the EDP enzymes are being expressed. With further work using proteomics
and metabolomics, we could create a clearer picture that could explain the little to no EDP
activity we detect in our strains. Recently, a new study has suggested the presence and activity
of a native EDP in Synechocystis 6803 through a series of knockout experiments, thus another
approach would be alternatively overexpressed these native genes for better EDP expression
(Chen et al. 2016). In addition, Synechococcus elongatus 2973 has enormous potential to
improve cyanobacterial productions, and moving towards utilizing this strain for commodity
products may provide a low cost-high profit bio-based production.

4.4 Methods
4.4.1 Cultivation for transient labeling experiments.
All cultures used were grown on BG-11 medium lacking citrate (pH 8.0-8.5) at 38 ºC. A 8-test
tube (max cap. 85 mL) multi-cultivator system (MC 1000, Photon Systems Instruments, Czech
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Republic) with a working volume of 40 mL provided cells with 3% CO2 aeration (2000 mL/min)
and 500 μmol photons•m-2•s-1 for isotopic labeling experiments. Except Synechococcus 7942 was
grown under 300 μmol photons•m-2•s-1. Fresh cells were inoculated in PBR (3% inoculation
ratio). Seed cultures were grown in 125 mL-shaking flasks open to atmospheric CO2, at 38 ºC,
250 rpm and 100 μmol photons•m-2•s-1. For the labeling experiment, a 2 mL aliquot of
NaH13CO3 (Sigma Aldrich, St Louis) was injected into each PBR during exponential phase for a
final concentration of 4 g/L of NaH13CO3. Each test tube of culture in the PBR was quenched at
different time intervals after the 13C-pulse ranging from 20 seconds to 2 hours.
4.4.2 Metabolite extraction and analysis.
A liquid N2 bath was used to quench the metabolism. Briefly, 50mL centrifuge tubes containing
10 mL BG-11 medium (no carbon) were placed in liquid N2 to pre-chill the media. Then cultures
after

13

C-pulse were quickly poured into centrifuge tubes submerged in a liquid N2 bath. Once

temperature dropped below 4oC, samples were then centrifuged at ~0 °C. The pellets were mixed
with 7:3 methanol: chloroform extraction solution and shaked overnight at 4oC. Samples were
then freeze-dried and stored at -80OC until LC-MS analysis.

Ion-pairing LC-MS/MS was

performed at the Proteomics and Mass Spectrometry Facility, Donald Danforth Plant Science
Center, St. Louis, MO. The labeling of organic acids were quantified using hydrophilic
interaction liquid chromatography (HILIC) coupled to electrospray time-of-flight MS at Joint
Bio-Energy Institute, CA. Flux calculations based on the

13

C transient labeling results were

modeled using INCA(Young 2014).
4.4.3 Strain construction.
Enzymes were purchased from New England BioLabs, Inc (Ipswich, MA) and oligonucleotides
were purchased from Integrated DNA Technologies (Coralville, IA). The EDP operon from R.
opacus (g6pdh, edd, eda) and EDP genes from E. coli (edd, eda) were amplified via PCR.
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Plasmids were developed using the Golden Gate assembly protocol. Antibiotic concentrations
used were the following: spectinomycin (100 µg/mL), gentamycin (10 µg/mL), and
chloramphenicol (34 µg/mL. The developed plasmids were transformed into Synechocystis 6803,
the protocol further detailed in published study(Immethun et al. 2016). Plasmid transformations
were confirmed via colony PCR. Double homologous recombination was used to knockout gnd.
EDP mutants (from E. coli) were tested using reverse transcription PCR (RT-PCR).
4.4.4 Cultivation conditions for EDP engineered strains.
For media preparation, all chemicals were purchased from Sigma Aldrich (Saint Louis, MO,
USA). Cells were grown in BG-11 medium at 30°C under light-activated dark condition (~30
minute light pulse per day) in approximately ~25 mL cultures in 250 mL Erlenmeyer flasks.
pBAD-ED(roa) and Δgnd were grown with 1 g/L of 1-13C glucose, while pTrc-ED(eco) and
6803 were grown with 2 g/L of 1-13C glucose. Antibiotics were added as needed. Seed culture
(EDP mutants) were grown in the light and supplemented with 5 mM glucose, 2 g/L NaHCO3,
and if necessary 5 mM sodium pyruvate, 0.2 g/L malate and 100 mM arabinose for induction.
All cultures were started at an initial OD730 of 0.4. The final ODs at time of harvesting were
2.237, 1.115, 3.634, 0.422 (in the order as they appear in the table 4.1).

4.4.5

Isotopomer analysis of proteinogenic amino acids.

The incorporation of labeled carbon into proteinogenic amino acids was measured by GC-MS
(Hewlett-Packard model 7890A, Agilent Technologies). Biomass pellets were hydrolyzed by 6
M HCl at 100°C. The resulting mixtures were subsequently air-dried and derivatized with N-tertbutyldimethylsilylN-methyltrifluoroacetamide (TBDMS) prior to GC-MS analysis(You et al.
2012). The amino acid MS data ( [M-57]+ and [M-85] +) were corrected for natural isotopic
abunadance using the following published software (Wahl et al. 2004b). Isotopomer labeling
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fractions (m+0, m+1, m+2, etc.) represent fragments containing unlabeled, singly labeled, doubly
labeled amino acids, and so on.
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5 Chapter Five: Examining Escherichia coli glycolytic pathways,
catabolite repression, and metabolite channeling using Δpfk
mutants
This chapter has been reproduced from the following publication:
Hollinshead, W.D., Rodriguez, S., Martin, H.G., Wang, G., Baidoo, E.E., Sale, K.L., Keasling, J.D.,
Mukhopadhyay, A., & Tang, Y.J. Examing Escherichia coli glycolytic pathways, catabolite repression,
and metabolite channeling using Δpfk mutants. Biotechnology for Biofuels. 9:212 (2016) (I contributed to
pathway engineering, and analysis of mutant strains).

Abstract
Glycolysis breakdowns glucose into essential building blocks and ATP/NAD(P)H for the cell,
occupying a central role in its growth and bio-production. Among glycolytic pathways, the
Entner Doudoroff pathway (EDP) is a more thermodynamically favorable pathway with fewer
enzymatic steps than either the Embden-Meyerhof-Parnas pathway (EMPP) or the oxidative
pentose phosphate pathway (OPPP). However, Escherichia coli do not use their native EDP for
glucose metabolism. In this s study, overexpression of edd and eda in E. coli to enhance EDP
activity resulted in only a small shift in the flux directed through the EDP (~20 % of glycolysis
flux). Disrupting the EMPP by phosphofructokinase I (pfkA) knockout increased flux through
OPPP (~60 % of glycolysis flux) and the native EDP (~14 % of glycolysis flux), while
overexpressing edd and eda in this ΔpfkA mutant directed ~70 % of glycolytic flux through the
EDP. The downregulation of EMPP via the pfkA deletion significantly decreased the growth rate,
while EDP overexpression in the ΔpfkA mutant failed to improve its growth rates due to
metabolic burden. However, the reorganization of E. coli glycolytic strategies did reduce glucose
catabolite repression. The ΔpfkA mutant in glucose medium was able to cometabolize acetate via
the citric acid cycle and gluconeogenesis, while EDP overexpression in the ΔpfkA mutant
repressed acetate flux toward gluconeogenesis. Moreover, 13C-pulse experiments in the
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ΔpfkA mutants showed unsequential labeling dynamics in glycolysis intermediates, possibly
suggesting metabolite channeling (metabolites in glycolysis are pass from enzyme to enzyme
without fully equilibrating within the cytosol medium). In conclusion, we engineered E. coli to
redistribute its native glycolytic flux. The replacement of EMPP by EDP did not improve E. coli
glucose utilization or biomass growth, but alleviated catabolite repression. More importantly, our
results supported the hypothesis of channeling in the glycolytic pathways, a potentially
overlooked mechanism for regulating glucose catabolism and coutilization of other substrates.
The presence of channeling in native pathways, if proven true, would affect synthetic biology
applications and metabolic modeling.
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5.1 Background
E. coli has three native glycolytic pathways: EMPP, EDP, and OPPP. The EMPP
employs ten enzymatic steps to yield two pyruvate, two ATP, and two NADH per glucose
molecule (Romano and Conway 1996), while OPPP serves as an oxidation route for NADPH
synthesis. In E. coli, glucose metabolism mainly relies on the EMPP and the OPPP, while the
EDP primarily remains inactive except during growth with gluconate (Eisenberg and Dobrogosz
1967). The EDP utilizes only five enzymes to produce one pyruvate, one glyceraldhyde-3phosphate, and one NADPH per glucose molecule (Fig. 5.1). With further conversion of
glyceraldhyde-3-phosphate via the lower EMPP, the two pathways (EDP and EMPP) result in
the same net production of pyruvate. However, the EMPP contains thermodynamic bottlenecks,
comprising of fructose 1,6-bisphosphate aldolase and triose-phosphate isomerase. The EDP
avoids both these unfavorable reactions (at the expense of ATP yield), and requires substantially
less enzymatic protein than the EMPP (Flamholz et al. 2013). Its end-products (glyceraldehyde
3-phosphate and pyruvate) are precursors of the non-mevalonate pathway and thus EDP
upregulation has been proven to improve the yields of isoprenoids (Li et al. 2015; Liu et al.
2014; Ng et al. 2015). In addition, the EDP may also alleviate oxidative stress (Chavarría et al.
2013; Klingner et al. 2015) and improve NADPH generation without the loss of carbon (i.e.,
CO2) (He et al. 2014).
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Figure 5.1 Redistribution of fluxes between the three primary glucose catabolic pathways
Redistribution of fluxes between the three primary glucose catabolic pathways: EMPP (red),
EDP (blue), and OPPP (orange) via the knockout of pfkA and overexpression of EDP genes (edd
and eda). Table on the right presents the estimated flux ratio between the three pathways for each
strain. The dashed arrows represent a possible interference (unannotated) source from glycogen
metabolism (Long et al. 2016).
The EDP relies on two unique enzymes phosphogluconate dehydratase (edd) and 2dehydro-3-deoxyphosphogluconate aldolase (eda), which are separate from the enzymes shared
with the EMPP and OPPP. In wild type (WT) E. coli, EDP flux is negligible. Δpgi (G6PF6P,
encoding glucose-6-phosphate isomerase), Δpfk (F6PFBP, encoding phosphofructokinase), or
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overexpression of OPPP may redirect glycolytic fluxes and increase EDP activity (Seol et al.
2016; Toya et al. 2010). Δpgi mutant has measureable EDP flux (up to ~15% of glycolysis), but
grew and consumed glucose more slowly than the WT strain. Δpgi mutant may recover its
growth rate by either increasing acetate overflow or activating the glyoxylate shunt after adaptive
evolution (Fong et al. 2006). Moreover, some bacterial species with exclusive EDP activity (e.g.,
Rhodococcus opacus) can co-utilize glucose with other substrates (Hollinshead et al. 2016).
Thus, we were curious if the presence of a highly active EDP could alleviate E. coli glucose
catabolite repression and promote cell growth. To re-organize the glycolytic pathways, we
engineered and characterized ΔpfkA mutants (deletion of phosphofructokinase I, important in the
regulation of glycolysis-gluconeogenesis, Fig. 5.1). Through growth experiments and

13

C-

labeling, we elucidated E. coli physiological changes and its capability for simultaneous
utilization of carbon substrates. Finally, ΔpfkA mutants also allowed us to evaluate the
hypothesis of the existence of metabolite channeling in glycolytic pathways (Shearer et al. 2005).

5.2 Results
5.2.1 Overexpression of EDP in E. coli
Overexpressing edd and eda in the wild type (WT) strain reduced the flux (~20%)
through EMPP and OPPP. Despite the increased EDP activity, the growth rate of the EDP
overexpressing strain decreased by ~30% compared to WT (Table 5.1). To confirm the tradeoff
from metabolic burdens imposed by antibiotics and plasmid/protein expression, we replaced
EDP genes with the gene encoding for yellow fluorescent protein (YFP). The YFP-expressing
strain had a similar reduced growth. A recent study found that the insertion of EDP (pgi, zwf, pgl,
edd, eda from Z. mobilis) into E. coli chromosome also repressed the growth of the engineered
strain(Ng et al. 2015a).
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Table 5.1 Strains/Plasmids Used
Plasmids/
Strains

Description

Maximal JBEI
Growth
ICE
-1
Rate (h ) Codes

Source

-

-

gene -

-

(Lee et al.
2011)
This study

BW25113

Strains
Keio collection WT(rrnB3 ∆lacZ4787 0.78±0.02 hsdR514 ∆araBAD567 ∆rhaBAD568 rph-1 )

(Baba et al.
2006)

JW3887
WH01

BW25113 ∆pfkA
BW25113 (pBbE5c-YFP)

0.18±0.02 0.56±0.07 JBEI14575

This study

WH02

JW3887 (pBbE5c-YFP)

WH03

BW25113 (pEDW)

WH04

JW3887 (pEDW)

0.13±0.01 JBEI14585
0.49±0.02 JBEI11465
0.18±0.01 JBEI11468

Plasmids
pBbE5c-YFP Backbone vector expressing YFP
Pedw

Derived from pBbE5c-YFP with
replaced by edd and eda

This study
This study
This study

To further improve EDP flux, the Keio collection ΔpfkA (phosphofructokinase I,
F6PFBP) mutant was used (Baba et al. 2006). The phosphofructokinase has two isoenzymes
(pfkA and pfkB) with pfkA as the primary enzyme responsible for the conversion of F6P to FBP
(Fraenkel 1986). 13C-fingerprinting revealed that the ΔpfkA mutant (JW3887) distributed glucose
flux through the OPPP (~62%), the EDP (~14%) and the EMPP (~24%) (Fig. 5.1). The pfkA
knockout increased cell lag phase, and reduced both cell growth rate and acetate overflow
(Supporting Fig. S5.1). This is because the glycolytic flux reorganization can cause metabolic
burdens, cofactor imbalances, and reduced carbon yield due to CO2 loss from the high OPPP flux
(Seol et al. 2014). Overexpressing EDP in the ΔpfkA mutant (resulting in strain WH04) raised the
EDP flux to ~72% and reduced the EMPP flux to ~18% (Fig. 5.1). WH04 grew much faster than
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WH02 (the ∆pfkA mutant with YFP overexpression) (Table 5.1), indicating a beneficial impact
of EDP in the absence of EMPP.
5.2.2

Removal of Glucose Carbon Catabolite Repression
Lignocellulose hydrolysate contains glucose, xylose and acetate. However, carbon

catabolite repression (CCR) inhibits hosts from consuming diverse substrates simultaneously
(i.e., E. coli mainly consumes glucose in a glucose/xylose medium). The CCR is often explained
by glucose inhibition on the synthesis of enzymes involved in catabolism of other carbon
sources, while recent studies suggest the presence of subpopulations within E. coli cultures can
have different carbon utilization hierarchies (Beisel and Afroz 2016; Koirala et al. 2016). To
investigate glucose catabolite repression, we grew the strains with a mixed carbon source of 10
g/L of glucose and 6 g/L of xylose, and measured the consumption of the two sugars (Fig. 5.2A
and Fig. 5.2B). The ΔpfkA mutant (JW3887) simultaneously consumed glucose and xylose, and
xylose co-utilization nearly doubled the growth rate compared to its glucose-only culture (Fig.
5.2A). WH04 can also uptake xylose with glucose, and xylose addition reduced the strain’s lag
phase (Fig. 5.2B). Moreover, the assimilation of xylose into biomass was determined through
13C-experiments (cultures fed with

13

C6-glucose and unlabeled xylose). The fraction of xylose

incorporated into proteinogenic amino acids during the exponential phase was measured (Fig.
5.2C). For both JW3887 and WH04, the xylose incorporation was ~50% (Fig. 5.2C), much
higher utilization than in the WT strain. Therefore, the removal of one pivotal EMP enzyme,
phosphofructokinase I, alleviated glucose catabolite repression.
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Figure 5.2 Glucose and xylose co-utilization
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Profile of growth (open square), acetate production (star), and consumption of glucose (open
circle) and xylose (open triangle) in mutant strains: a. ∆pfkA mutant (JW3887) and b. WH04
grown with glucose and xylose. OD600 of cultures grown solely with glucose are also shown
(closed circles). c 13C isotopic labeling tracing in cultivations fed 10 g/L of 13C6-glucose and
6 g/L of unlabeled xylose. Xylose contribution (fraction of 12C) in proteinogenic amino acids is
graphed for the three strains (2 % isotopic measurement errors were applied) (n = 2).

Acetate, another common component in lignocellulosic hydrolysate, has to be
metabolized through gluconeogenesis (Zhao and Shimizu 2003a). ΔpfkA is expected to alleviate
the EMPP repression on gluconeogenesis, and improve the co-utilization of glucose and acetate.
To test this hypothesis, the mutants (JW3887 and WH04) were grown with 10 g/L of glucose and
supplemented with 6 g/L of sodium acetate during the early exponential phase (Fig. 5.3A, 5.3B
and 5.3C). Although acetate may interfere with intracellular pH and hinder E. coli growth (Luli
and Strohl 1990; Xiao et al. 2013), JW3887 was able to co-utilize acetate with little effect on its
growth. Acetate incorporation into biomass measured via cultures fed with unlabeled glucose
and fully labeled acetate revealed that the mutant utilized acetate for biomass synthesis with
significant incorporation of 13C into TCA and glycolysis-derived proteinogenic amino acids (Fig.
5.3D). In contrast, the glycolytic amino acids: Ala, Phe, and Ser were unlabeled in WT under
similar mixed carbon cultures, these amino acids being derived from PYR, PEP, and 3PG,
respectively. Therefore, ΔpfkA (JW3887) could co-utilize acetate to generate TCA cycle
metabolites and glycolytic intermediates via up-regulation of gluconeogenesis. However,
introduction of EDP into the ΔpfkA mutant inhibited gluconeogenesis, as revealed with a lack of
13

C Ala/Phe/Ser in WH04 biomass (Fig. 5.3D).
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Figure 5.3 Glucose and acetate co-utilization

The growth (open square) and substrate consumption (glucose, open circle; acetate, open
triangle) in mutant strains initially fed 10 g/L of glucose then supplemented with 6 g/L of
sodium acetate (denoted in figure): a ∆pfkA (JW3887) and b WH04. OD600 of cultures grown
solely with 10 g/L of glucose are also included (closed circles). c Maximal growth rate of WT,
JW3887, and WH04 in cultures supplemented with 6 g/L of sodium acetate during early
exponential phase (black bar). Control cultivations (no acetate; white bar) were supplemented
with 6 g/L of sodium chloride to normalize for ion effects. d 13C tracing in cultivations fed
10 g/L of unlabeled glucose and 6 g/L of fully labeled 13C2-acetate. Acetate contribution (13C
fraction) in proteinogenic amino acids are shown for the three strains. (n = 2).
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5.2.3 Dynamic labeling pattern for sugar phosphates in ΔpfkA mutants
We grew WT and the ΔpfkA mutants (WH04 and JW3887) with unlabeled glucose into
the mid-exponential growth phase, and then we added uniformly

13

C6-labeled glucose into the

cultures. The resulting kinetics of 13C-labeling incorporation in key metabolites were examined.
The WT demonstrated very fast metabolite turnover such that most metabolites’ labeling reached
isotopic steady state in 15 seconds (Fig. 5.4A and Supporting Fig. S5.2). This observation is
consistent with the rapid EMPP turnover rates previously reported (Nöh et al. 2007). In contrast,
WH04 had lower rates of labeling incorporation, in which G6P and 6PG were labeled slower
than their downstream metabolites (3PG and PEP) (Fig. 5.4B, Supporting Fig. S5.3). Similarly,
the

13

C-pulse experiment for JW3887 also revealed that 3PG and R5P reached isotopic steady

state more quickly than their higher pathway metabolites (G6P and 6PG), revealing unusual
labeling for both EMPP and OPPP (Supporting Fig. S5.4).
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Figure 5.4 Dynamics labeling of central metabolites.
Dynamics labeling of central metabolites. Labeling dynamics in selected metabolites postpulse
of13C6-glucose into a Wild Type and b WH04. c Relative metabolite peak ratio of central
metabolites in WT and ED mutant strains. The glycolysis key node (3PG) is used as the base of
comparison. d Ratio of WT pool size to mutant pool size for G6P, 6PG, and MAL. The
metabolite pools in two mutants, ∆pfkA (JW3887) and WH04, were measured via isotopomer
ratio analysis. Asterisk 6PG measurement for WT was below detection
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The unsequential

13

C labeling patterns for glycolysis intermediates in ΔpfkA mutants

could be explained by metabolite channeling (Fig. 5.5A): intermediates in metabolic pathways
are passed from enzyme to enzyme without equilibration within the cellular medium (Williams
et al. 2011). For example, a large unlabeled metabolite pool formed outside of the ‘channel’
could dilute the labeled metabolite concentration, resulting in a slow labeling incorporation of
the bulk metabolite, as measured by LC-MS methods. The downstream metabolites, however,
retain their fast rates with their production primarily from the metabolite pool within the
‘channel’. In a previous study, in vivo evidence discovered that EMPP intermediates are mainly
concentrated within the ‘channel’ with minimal mixing with the cytoplasmic pool (Shearer et al.
2005). In vitro studies also suggest that the OPPP metabolites (e.g., 6PG) are highly channeled
(Debnam et al. 1997; Malaisse et al. 2004). In this study, disruption of EMPP channel by the
knockout of pfkA caused a bottleneck in the conversion of F6P to FBP, which likely allowed
hexose6P metabolites to accumulate within the cytosol. LC-MS peak abundances and isotopomer
ratio analysis (Fig. 4C and 4D) further confirmed that ∆pfkA (JW3887) and WH04 had larger
G6P and 6PG pool sizes than those in the WT. During 13C-pulse experiments, the unlabeled G6P
and 6PG amassed in the cytosol could significantly slow the measured labeling of bulk
hexose6P, causing 13C to appear more gradually than in their downstream metabolites (3PG and
PEP). Although there could be other reasons for the observed labeling patterns in ∆pfkA mutants,
such as activation of unknown pathways, unknown influence of various side reactions, or the
effect of cell subpopulations, channeling is one logical explanation which would have a great
impact on the field.
5.2.4

Fluxome response to changes in glycolytic pathway utilization
Flux balance analysis (FBA) was used to predict growth and flux distribution under

different glycolytic pathways and carbon substrates. Using the measured glycolytic flux ratios,
94

substrate utilization, and acetate production as constraints, we performed FBA simulations on the
mutant strains using maximal biomass growth as the objective function (Fig. 5.6a, b). FBApredicted growth rate of WH04 agreed with the experimentally measured the glucose-based
growth rate, while xylose and acetate co-utilization models show certain discrepancies. The
measured growth rates of JW3887 were generally below the growth rates predicted by FBA
(Fig.5. 6c). The knockout of pfkA may have unknown effects that cause a suboptimal metabolism
for biomass synthesis. Unlike the WT strain, FBA predicted that ΔpfkA mutant and WH04
upregulated the glyoxylate shunt and maintained low activity of anaplerotic pathways for glucose
metabolism (Fig. 5.6a). Compared to WT, the absolute fluxes of energy production (ATP,
NADH, and NADPH) rate in mutants were reduced (Fig. 5.6b). FBA improved our overview of
the central metabolic responses to our glycolysis flux reorganization.
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Figure 5.5 FBA of ΔpfkA (JW3887) and WH04.
The FBA was constrained by the 13C-flux ratio and optimized for biomass accumulation. a Heat
Map of the difference (Fluxmutant-FluxWT) in the optimal fluxes (normalized to total carbon
uptake rate, which was set to one) between mutant strains (ΔpfkA-JW3887 and WH04) and WT
(green showed increased relative flux compared to wild type, red showed decreased relative flux
compared to wild type). b Absolute total productions of ATP, NADH, and NADPH. c Simulated
and measured growth rates of the different strains and growth conditions. The wild-type strain
glucose uptake rate was assumed to be 8.5 mmol/h/g DCW
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5.3 Discussion
Glycolytic pathways hold considerable control over carbon utilization and biosynthetic
efficiency. The knowledge of their regulation is crucial for designing optimal microbial
production strains. For example, the desire to use cheap cellulosic feedstock has prompted
metabolic engineers to develop microbial hosts that utilize both 6- and 5-carbon sugars,
simultaneously (Kim et al. 2010; Nieves et al. 2015). However, carbon catabolite repression
(CCR) prevents the simultaneous consumption of other carbon sources. CCR is believed to act in
E. coli by preferentially directing resources to consume glucose more efficiently by regulating its
sugar transporters and carbon degradation pathways (Gorke and Stulke 2008). Approaches such
as adaptive evolution and overexpression of xylose transport and catabolic genes have been
tested to minimize CCR (Kim et al. 2010). The knockout of phosphoenolpyruvate-dependent
glucose phosphotransferase system (PTS, the primary transport system for glucose) has also been
shown to be an effective way to enable glucose and xylose co-utilization (Chiang et al. 2013;
Jung et al. 2015; Lu et al. 2016; Su et al. 2015), but has a negative effect on glucose uptake and
growth rates. In this study, ΔpfkA mutants also showed no CCR and employed xylose coconsumption to increase its growth rate. ΔpfkA caused an increased pool size of G6P that may
have inhibited PTS and decreased biomass accumulation (Chassagnole et al. 2002; Morita et al.
2003).
Gluconeogenesis is usually inactive under high glucose concentrations as it is regulated
by phosphofructokinase and pyruvate kinase. The lack of EMPP flux could facilitate
gluconeogenesis for utilization of non-sugar based substrates. This is seen in Rhodococcus
opacus, which lacks pfk activity and shows simultaneous gluconeogenesis and EDP for sugar and
phenol co-utilization (Hollinshead et al. 2016). In this study, ΔpfkA mutants actively utilized
acetate from the glucose medium. This observation is encouraging since acetate is a notorious
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inhibitor in E. coli cultivation, because acetate can freely diffuse through the cell membrane and
disrupt the intracellular pH (Ding et al. 2015; Repaske and Adler 1981; Xiao et al. 2013).

13

C-

labeling analysis of Asp and Glu revealed that both JW3887 and WH04 actively employed the
TCA cycle to degrade

13

C-acetate in the presence of glucose. However, increased EDP flux in

WH04 repressed the gluconeogenesis activity since EDP overexpression drives high flux
towards the lower portion of the EMPP.
Despite being more thermodynamically favorable and requiring ~5-fold less enzymatic
protein (Flamholz et al. 2013), the E. coli mutants grew slower than WT after overexpression of
EDP genes. One reason could be the lower ATP yield of EDP as compared to EMPP (this
explanation is questionable since respiration remains the main ATP production route in all
aerobic cultures via our FBA simulations). The other explanation is metabolite channeling. The
intracellular environment contains high amounts of macromolecules (30-60% of cell volume)
creating a crowding effect within the cell that can reduce metabolite diffusion, thus channeling is
an important mechanism for in vivo enzyme reactions (Zhang 2011). Channeling can be naturally
accomplished in the cell via electrostatic interactions, intramolecular tunnels, and small spatial
distances between enzymes (Wheeldon et al. 2016). In eukaryotic cells, channeling is present for
the TCA cycle and other pathways, as eukaryotes have organized their pathways within
organelles (Debnam et al. 1997; Malaisse et al. 2004). Pathways in E. coli have also been found
to demonstrate forms of channeling, such as for fatty acid type II synthesis pathway (Janßen and
Steinbüchel 2014; Mathews et al. 2013). As shown in this study and previous studies (Noor et al.
2014), E. coli EMPP channeling would significantly improve reaction thermodynamics and
overcome kinetic obstacles. Thereby, it could be an important factor in WT and WH03
preference for EMPP rather than the EDP route.
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If labeled G6P was being channeled in our experiments, then it must be channeled from its
conversion of glucose to G6P. In E. coli cells, this primarily is the job of the glucose transport
system, PTS, which uses PEP to uptake glucose and convert it to G6P. Using 1-13C glucose as
the isotopic tracer, we estimated the flux redistribution after the knockout of ptsG using WUFlux
(13C-MFA software)(He L et al. 2016). In Table 6.1, the flux distribution between the three
glycolytic pathways show that the knockout of ptsG, effectively disrupting the PTS transport
system, had a significant reduction in the flux through EMPP, a 60% increase of OPPP flux, and
a small flux through EDP. Flores et al., 2002 similarly conducted flux analysis on ΔptsG to near
identical flux results, while finding that despite the reduction in flux the knockout increased the
enzyme levels of EMPP enzymes(Flores et al. 2002). The small flux through EDP is too small to
firmly state that the disruption of the channel also allows EDP to be a more competitive pathway.
Therefore we introduced our plasmid pEDE (also denoted pEDW) into both the WT (BW25113)
and ΔptsG. The resulting flux redistributions show much higher EDP flux enhancement in the
strain containing an inactive PTS system as compared to active PTS transport. This observation
is consistent with our hypothesis that the PTS system may play a part in metabolite channeling
within EMPP.
Table 5.2 Ratio of fluxes through glycolytic pathways in E. coli strains as determined by
WUFlux.

The channeling process is difficult to study noninvasively, particularly in the central
metabolism. In an early study by the Kohl group, E. coli was engineered so that the mutants
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could uptake both 14C-glucose and unlabeled sugar phosphates (Shearer et al. 2005). The authors
found that the presence of unlabeled FBP in the culture medium did not dilute
intermediates or

14

14

C EMPP

CO2, indicating a high degree of EMPP channeling. Debham et al., 1997

isolated enzymes from the oxidative pentose phosphate pathway; they found the rate of

14

C-

glucose to 14CO2 was not affected by providing external G6P or 6PG. Other pathways have also
been investigated. Vélot, 2000 mutated citrate synthase and malate dehydrogenase in
Saccharomyces cerevisiae to test the interactions of two enzymes, and found that while the
mutations had little effect on their individual kinetic efficiencies it still caused a deficiency in the
TCA cycle. In the present study, we performed

13

C-pulse experiments to measure the labeling

dynamics in WT and the ΔpfkA mutants (Supporting Fig. S5.2-S5.4). Our results supported the
hypothesis that metabolites are not equilibrated in the cytoplasm (Fig. 5.6A & 6B). In this study,
ΔpfkA mutants had slower metabolite transfer rates, and accumulated the upstream hexose6Ps
outside of the channel. The resulting presence of two pools of the same metabolite allowed

13

pulse experiments to detect unsequential metabolite labeling through the EMPP.

Figure 5.6 Schemes of hypothesized channeling and its influence on catabolite repression.
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An

enzymatic

pathway

of

sequential

metabolites

W,

X,

Y,

and

Z

forms

a

channel. Delta represents the presence of a bottleneck that limits flux through the channel. a In a
fully channeled network, most substrates exist within the channel with few substrates existing in
cytosol. The pulse of 13C (asterisk) into the channeled pathway results in sequential and fast
labeling of metabolites W, X, Y, and Z. b In a fractured channel, a disturbance in an enzyme
(X→Y) causes accumulation of X in the cytosol, which is metabolically less active. After the
pulse of 13C (asterisk), the labeling of bulk X* will be diluted by unlabeled Xo in the cytosol
during LC–MS analysis. The downstream metabolites Y and Z may show faster 13C-labeling if
their unlabeled pools in cytosol are small. In this case, the pulse of 13C and measurement of
metabolite labeling dynamics can capture the features of channeling. c Substrate channeling can
be another factor leading to CCR. The presence of channeling favors fast W conversion through
the channeled pathway, while diffusion of cytosol metabolite (X) from secondary substrate (U)
into channeled pathway becomes limited. d Catabolite repression is reduced if the channeled
pathway flux is downregulated, allowing for cytosol X to diffuse into the channeled pathway

Channeling may have several implications on our understanding of cell physiology. First,
metabolite channeling avoids diffusion limitations and thus significantly improves bioconversion
efficiency (Wheeldon et al. 2016). Channeling would explain the robustness of natively evolved
pathways for biosynthesis, encouraging synthetic biologists to replicate channeling as a strategy
to improve heterologous pathway efficiency (e.g., co-localization/compartmentalization of
overexpressed enzymes) (Sarria et al. 2014). Second, it necessitates that we rethink the in vivo
Gibbs free energy or kinetics typically reported in studies, since the global metabolite pool
measurement does not reflect the local substrate concentrations (The notion of ‘one perfectly
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mixed solution’ may be a poor reflection of the cell ‘in vivo’). This presents complications with
metabolic modeling. Third, metabolite channeling could affect steady-state

13

C-Metabolic Flux

Analysis, because channeling may prevent the carbon randomization during conversion of a
symmetric metabolite or introduce bypass routes for 13C labeling (Williams et al. 2011). Finally,
we hypothesize that channeling could be another factor behind CCR. At high growth rates, the
EMPP is capable of reaching fast glucose catabolic rates such that metabolites derived from
other substrates (e.g., xylose) cannot sufficiently diffuse into the EMPP channel (i.e., glucose
catabolite repression). During slow growth conditions, glucose catabolic flux decreases. This
favors diffusion of metabolites from cytosol into the EMPP channel and encourage the coutilization of the secondary substrate (Fig. 5C & 5D). In reality, inhibition of EMPP flux (e.g.,
removal of glucose transporter ΔptsG or glucose-limiting cultures) allows E. coli to cometabolize glycerol with glucose (Yao et al. 2016).

5.4 Conclusion and Future Work
We’ve re-wired E. coli’s central metabolic network through a pfkA knockout and EDP
overexpression. The altered strains alleviated glucose catabolite repression, and could be
beneficial in biosynthesis from renewable cellulosic hydrolysates. Physiological analyses of
different glycolytic strategy clearly revealed that despite the theoretical prediction that EDP is a
preferred glycolysis pathway based on both thermodynamics and the cost of enzymatic protein,
the cell prefers EMPP for optimal growth. The results of 13C-pulse experiment revealed a form of
EMPP channeling that, if proven, could significantly affect our understanding of reaction
thermodynamics, flux analysis, and synthetic biology applications.
Steady state

13

C-MFA relies heavily on metabolite labeling inferred from measured

amino acid labeling distributions, but if reactions are channeled and bypass amino acid
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production, this could lead to misleading labeling distributions. Proving the hypothesis of
metabolite channeling is important as it would have a vast impact on Gibbs free energy
estimations, metabolic modeling, metabolic engineering, and genome-to-phenome mapping.
However, proving metabolite channeling is also very challenging as most methods are indirect
and have other possible explanations. Dynamic labeling experiments are one method that has
provided much evidence, but most have been completed on engineered strains which remained
unclear on how that shifts the cells’ behavior and unclear on how the kinetics of side reactions
effects the labeling. In addition, the quenching and extraction necessary for dynamic labeling
leaves possible problems with trace extracellular metabolite interference, effects of stressed
conditions (e.g., cold shock), and culture heterogeneity. The best plan is to combine dynamic
labeling studies with more physical evidence (e.g., of protein interactions) to further our
understanding of the mechanism employed for channeling. Synthetic biologists have already
attempted to recreate metabolite channeling through engineering enzyme co-localizations via
direct protein fusions, protein surfaces’ interactions, and protein or DNA scaffolds(Baek et al.
2013; Dueber et al. 2009; Lee et al. 2013; Moon et al. 2010; Sachdeva et al. 2014; Wang and Yu
2012). However, in some of these cases, the introduced inclusions bodies have been found to
negatively impact cell division(Lee et al. 2013).

5.5 Methods
5.5.1 Chemicals
Glucose, [1-13C] glucose, [U-13C] glucose, [U-13C] acetate, and all other chemicals unless
otherwise stated were purchased from Sigma Aldrich (St. Louis, MO). Q5 High Fidelity 2X
Master Mix was obtained from New England Biolabs (Ipswich, MA), all other enzymes were
purchased through Thermo Scientific (Waltham, MA).
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5.5.2 Construction of strains and plasmids
All plasmids were developed from a BglBrick expression vector, pBbE5c-YFP, which contains
a ColE1 origin of replication, chloramphenicol resistance and LacUV5 promoter (Lee et al.
2011).

The

genes,

phosphogluconate

dehydratase

(edd)

and

2-dehydro-3-

deoxyphosphogluconate aldolase (eda) were PCR- amplified from genomic DNA of E. coli K-12
MG1655. The plasmid pEDW was assembled from the PCR-amplfied genomic region from edd
to eda into pBbE5c backbone via Gibson assembly. Primers used for plasmid construction are
the following:
eddeda01_fwd: CTTTTAAGAAGGAGATATACATATGAATCCACAATTGTTACGCG
eddeda01_rev: CGAGTTTGGATCCTTACAGCTTAGCGCCTTCTACAGC
vecbac01_fwd: GGCGCTAAGCTGTAAGGATCCAAACTCGAGTAAGGATCTCC
vecbac01_rev:
CGCGTAACAATTGTGGATTCATATGTATATCTCCTTCTTAAAAGATCTTTTGAATTC
Table 1 lists the resulting mutant strains, their JBEI ICE registry numbers, and growth rates. All
strains generated at JBEI are available thought the JBEI Registry (https://acs-registry.jbei.org;
(Ham et al. 2012)). The plasmid was first transformed into DH10B for plasmid propagation, and
then verified by sequencing completed by Quintara (San Francisco, CA). After verification for
no mutations, the plasmid was transformed into Keio collection strains, BW25113 (WT) and the
∆pfkA mutant (JW3887) (Baba et al. 2006), obtained from the Yale E. coli Genetic Stock Center
(New Haven, CT).
5.5.3 Media Composition and Growth Conditions
Seed cultures were grown in LB for ~12 hours, then inoculated (2% v/v) in M9 minimal medium
overnight. Strains were then inoculated in fresh M9 minimal medium (~2% v/v). The M9
medium (pH=7~7.5) consisted of 11 g/L of 5X M9 salts (Sigma Aldrich, St. Louis, MO), 2mM
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MgSO4●7H2O, 0.1mM CaCl2●2H2O, 1 mg/L of Thiamine HCl, 3 mg/L of FeSO4●7H2O, and
trace minerals. Initial sugar concentrations were 10 g/L of glucose and 6 g/L of xylose. For
mutant cultures, 30 mg/L chloramphenicol and 10 mg/L kanamycin were supplied as needed. 50
µM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was used to induce plasmid borne genes at
early exponential growth phase. To study acetate co-utilization, 6g/L sodium acetate (or 6g/L
NaCl served as a control) were added at early phase of mutant cultures (OD600~0.2, pH~7.5) with
the IPTG induction. All cultivations were aerobic and conducted in 5 mL cultures in test tubes on
a rotary shaker at 250 rpm at 37 OC. For labeling experiments, unlabeled glucose was replaced
with 100% [1-13C] glucose or 100% [U-13C] glucose, and unlabeled acetate was replaced with
[U-13C] acetate.
5.5.4 13C-Pulse Experiments
Strains were grown in approximately 70 mL cultures in 250 mL Erlenmeyer flasks on a rotary
shaker at 250 rpm with 2g/L unlabeled glucose M9 media. In all 13C-pulse experiments, cultures
in exponential growth phase (pH=6~7) were pulsed with 5 mL ~60 g/L

13

C6-glucose stock

solution. To measure the 13C- incorporation into glycolysis metabolites over time, cultures were
harvested at different time points (from 15s to 3 minutes). The harvested samples were quenched
using the procedure of Fast-Cooling (Fu et al. 2015). Specifically, ~10mL culture was poured
into a 50mL falcon tube containing 2mL ice-cold M9 medium (no carbon source) and the tube
was immediately immersed in liquid N2. To facilitate heat transfer and avoid ice formation in the
sample solution during the liquid N2 bath, the sample solutions were manually agitated using a
digital thermometer. The sample solution could be cooled to 0 oC in 10 seconds. The ice-cold
samples were centrifuged at 0 °C for 3 minutes and the pellets were stored at -80 °C until
metabolite extraction.
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5.5.5 Sugar Measurement
Supernatant samples were taken in parallel experiments separate from cultures used for
optical density measurement to reduce the loss of volume. At each time point, at le ast 150 µL
of culture was extracted, centrifuged to remove cell biomass, and stored at -20 oC. Samples
were diluted by 2X and then filtered through 0.22 μm centrifugal filters. Samples were run on
an Agilent Technologies 1200 series HPLC equipped with an Aminex H column, the
concentrations were estimated based on standard curves(Rodriguez et al. 2016).
5.5.6 Amino acid extraction and GC-MS analysis
Amino acid extraction and GC-MS analysis were performed as described previously (You et al.
2012). Briefly, cell pellets from 5 mL cultures taken during the exponential phase were washed
with 0.9% (w/v) of NaCl solution, and then hydrolyzed in 6M HCl at 100 oC. The resulting
amino acids were derivatized by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide prior to
GC-MS analysis. For isotopic tracing, we used the fragments [M-15]+ or [M-57]+ (containing the
entire amino acid backbone) and [M-159]+ or [M-85] (containing the amino acid backbone after
loss of its first carbon). The natural isotopic abundance of derivatized amino acids was corrected
using a reported algorithm (Wahl et al. 2004a). The mass isotopomer distributions of alanine
and serine for the strains used are given in Supporting Table S5.1.
1-13C glucose was used to measure in vivo glucose catabolism: the OPPP cleaves the
labeled carbon as CO2; the EDP produces a 1st carbon labeled pyruvate; while EMPP results in
the labeled carbon present in the third position of pyruvate(Romano and Conway 1996). GC-MS
analysis of alanine (synthesized from pyruvate) can reveal this positional labeling as further
described previously (Borodina et al. 2005; Hollinshead et al. 2016; Klingner et al. 2015).
Equations 1-3 were solved for estimation of the flux ratios between the three pathways (without
considering metabolite channeling effect):
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𝐴𝑙𝑎100 =

𝐴𝑙𝑎000

𝑣𝐸𝐷𝑃
5
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 + 3 𝑣𝑂𝑃𝑃𝑃

5
𝑣𝑂𝑃𝑃𝑃 + 𝑣𝐸𝐷𝑃 + 𝑣𝐸𝑀𝑃𝑃
= 3
5
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 + 3 𝑣𝑂𝑃𝑃𝑃

𝐴𝑙𝑎001 =

(1)

(2)

𝑣𝐸𝑀𝑃𝑃
5
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 + 3 𝑣𝑂𝑃𝑃𝑃

(3)

where vEDP, vEMPP, and vOPPP are the estimated fluxes for the EDP, EMPP, and OPPP,
respectively. Alaxxx are the fractions of the isotopomer determined by fragmentation data, with 1
denoting a

13

Carbon isotope. For example, Ala100 is the fraction of alanine labeled at carbon

position 1, a unique isotopomer produced by the EDP. The calculated flux ratios are estimations,
which assume the reactions are irreversible.
5.5.7 Metabolite Extraction and LC-MS Analysis
After quenching, the cell pellet was suspended in 1 mL of cooled 7:3 methanol:chloroform
mixture. These samples were then placed on a rotary shaker at 250 rpm, overnight at 4 oC. The
methanol layer was separated with the addition of 500 µL of water, then filtered through an
Amicon Ultra centrifuge filter (3,000Da; EMD Millipore, Billerica, MA), lyophilized (-50 oC)
and reconstituted in 100 µL of acetonitrile-water (6:4, v/v). The samples were then analyzed via
liquid chromatography-mass spectrometry (LC-MS) using a SeQuant Zic-pHILIC column (EMD
Millipore, Billerica, MA, USA) in an Agilent Technologies 1200 Series HPLC system. The
mobile phase was composed of 15 mM ammonium carbonate (Sigma-Aldrich, St. Louis, MO,
USA) in water (solvent A) and 15 mM ammonium carbonate in 75% acetonitrile and 25% water
(solvent B). A flow rate of 0.2 ml/min was used, unless stated otherwise. Metabolites were
separated via gradient elution under the following conditions: 100% B (0 min), 82% B (4.4 min),
72% B (7.7 min), 60% B (9.7 min), 100% B (10.2 min), 100% B (12.5 min), 100% B (13 min,
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0.4 mL/min), and 100% B (18.5 min, 0.4 ml/min). The HPLC system was coupled to an Agilent
Technologies 6210 series time-of-flight mass spectrometer (for LC-TOF MS) via a MassHunter
workstation (Agilent Technologies, USA). A split ratio of 1:4 was used throughout. Drying and
nebulizing gases were set to 10 L/min and 25 lb/in2, respectively, and a drying-gas temperature
of 300°C was used throughout. Electrospray ionization (ESI) was conducted in the negative ion
mode and a capillary voltage of 3,500 V was utilized. The acquisition range was from 70-1000
m/z, and the acquisition rate was 0.86 spectra/s. Metabolite mass isotopomer distribution was
determined based on the ratio of the integrated peak area of the chosen isotopomer to the sum of
all the integrated peak areas of the possible isotopomers for the given metabolite.
5.5.8 Estimation of Pool Size via Isotope-ratio Approach
The relative pool size of key metabolites (G6P, 6PG, and MAL) were measured via an
isotope-based ratio approach, as modified from (Bennett et al. 2008). Wild type (BW25113) was
cultivated in 5 g/L of

13

C6-glucose and 1 g/L of fully labeled

13

C-sodium bicarbonate, which

generated 13C-metabolites as internal standards. The fully labeled WT biomass and the unlabeled
mutant cultures were quenched using liquid N2 as described earlier, then mixed together at 1:1
volume ratio for metabolite extraction. The ratio of WT metabolite pool size (labeled peak area)
to the mutant strains metabolite pool size (unlabeled peak area) was determined using LC-MS,
which provided a qualitative comparison of metabolite pool sizes between WT and mutants.
5.5.9 Flux Balance Analysis Constrained by Measured Flux Ratios
The E. coli Genome Scale Model iJO1366 (2251 metabolic reactions) was adapted for metabolic
modeling of mutants under the different growth conditions (Orth et al. 2011). Flux Balance
Analysis (FBA) chose objective function:
Maximize µ
Subject to: 𝐒 ∙ 𝐯 = 0
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𝐥𝐛 ≤ 𝐯 ≤ 𝐮𝐛
where S represents the stoichiometric matrix, v represents the matrix of reaction rates (fluxes),
while matrices lb and ub are the lower and upper bounds, respectively. Glucose, xylose, and
acetate uptake rates were fixed to measured values. Flux ratios determined by

13

C-analysis was

used to constrain fluxes through EMPP, EDP and OPPP (Fig. 1). As the activities of pfkA and
pfkB were lumped in iJO1366, the PFK reaction was not constrained. All generated fluxes were
normalized to total substrate uptake rate.

109

5.6 Supplemental Information for Chapter 5
Table S5.1. Mass Isotopomer Distribution of Alanine and Serine
BW25113

WH03

JW3887

WH04

m-57

Alanine

m+0
m+1
m+2
m+3

0.53
0.46
0.01
0.00

0.51
0.49
0.00
0.00

0.67
0.33
0.00
0.00

0.54
0.46
0.00
0.00

m+0
m+1
m+2

0.54
0.46
0.00

0.62
0.38
0.00

0.74
0.27
0.00

0.95
0.05
0.00

m-57

Serine

m+0
m+1
m+2
m+3

0.56
0.44
0.00
0.00

0.59
0.42
0.00
0.00

0.71
0.29
0.00
0.00

0.87
0.13
0.00
0.00

0.56
0.44
0.00

0.59
0.41
0.0

0.71
0.28
0.00

0.93
0.07
0.00

m-85

m-159
m+0
m+1
m+2

Note: All standard deviations are <0.02.
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Figure S5.1. Glucose Consumption in (A) JW3887-∆pfkA and (B) WH04

Figure S5.2. Dynamics of 13C-labeling Pulse Experiment for WT (BW25113).
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Figure S5.3. Dynamics of 13C-labeling Pulse Experiment for WH04.

112

Figure S5.4. 13C-Isotopic Incorporation kinetics in JW3887-∆pfkA glucose culture taken
immediately after 13C6-Glucose pulse (final labeled glucose concetrantion ~ 4 g/L). *Note
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6 Chapter Six: Conclusion and Future Directions
6.1 Conclusion
In metabolic engineering, we use the design-build-test-learn cycle in which we first design
an engineering strategy, build our engineered or adapted strains, and then test their performance.
The learn stage should then incorporate systems biology approaches to build better
understanding and awareness of any underlying barriers or bottlenecks to achieving our desired
goals. With the advancement in molecular cloning techniques and automation, researchers and
companies can now quickly design, build, and test strains in large quantities and at record speeds.
Systems biology approaches, specifically fluxomics, must now be adapted to provide
information for multiple strains with less turnover time and lower costs.
In this thesis, we were motivated by this need to develop the methodology discussed in
chapter 2 that included a high-throughput qualitative protocol. The method integrates parallel
13

C-isotopic experiments to build larger views of the flux topology in strains in under ~3 days

(growth of strain not considered in this estimate). The efficacy of this 13C-fingerprinting method
was successful in providing several novel insights in Rhodococcus opacus PD630, a promising
phenol-tolerant host for biodiesel production. Most importantly, the results strongly suggested an
active gluconeogenesis and Entner-doudoroff pathway (EDP) as a metabolic strategy supporting
the strain’s lack of carbon catabolite repression in phenol-glucose fed cultures.
In certain cases, quantitative flux analysis is often necessary to fully identify the influential
factors in a systems and comparative manner as demonstrated in Chapter 4.

13

C-Metabolic Flux

Analysis of Synechoccocus 2973 revealed many rational metabolic engineering strategies for
developing Synechocystis 6803 to become a more efficient autotrophic and heterotrophic
microbial cell factory. However, unknown biological constraints (incompatible heterologous
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enzymes, hidden regulation, or etc.) prevented our assay from detecting the activity of the
introduced EDP.
We’ve also explored increasing the EDP activity in E. coli for better carbon co-utilization in
Chapter 5. While it did relieve glucose catabolite repression on xylose, it failed to improve
glucose-acetate cultivations. Though, the down regulation of EMPP through the deletion of pfkA
was sufficient to relieve the glucose-xylose regulation as well as glucose-acetate regulation. In
addition, the

13

C labeling dynamics within the ΔpfkA mutants generated unusual labeling

distributions with early metabolites (G6P and 6PG) labeled slower than their subsequent
metabolites. While there may be other explanations behind the non-sequential labeling, we
hypothesize that this could be due to metabolite channeling (due to large metabolically inactive
pools of G6P & 6PG).

6.2 Future Directions
In this thesis, we have optimized

13

C-metabolism analysis tools, characterized promising

non-model organisms, and translated our findings into new engineering strategies for model
organisms that ultimately discovered possible hidden constraints in modifying central pathways.
This work is a move into discovering new strategies to improve bioprocess feasibilitie. For
example, this work demonstrated the importance of searching and developing new nonmodel
species.
For the future of bio-based productions, the field needs to incorporate economics and life
cycle analysis to clearly demonstrate that the particular scientific path has a road to success. For
example, new proposed projects should evaluate the potential theoretical yields that can be
accomplished, the potential profit margin of the process, and the energy yield. The biotechnology
field advertises itself as an environmentally-friendlier and energy-efficient alternative but most
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studies failed to evaluate using life cycle analysis the veracity of that claim. Moving forward, a
review of the current state of bio-based productions and the improvements needed to reach a
break-even point for success would help to rationally direct the field to worthwhile projects.
Finally, the use of 13C-metabolism analysis in examining metabolic shifts on fermentation would
be an interesting direction. As traditional chemical engineers greatly optimized synthetic reaction
engineering by improving their understanding of the mixing and state of the reactions within
reactors, bioprocess engineers must also investigate the hindrances experienced at production
scales to advance the scale-up process. Though the dynamic flux analysis of heterogeneous
bioreactor cultures makes this avenue an expensive venture, I believe this tool with careful
planning could illustrate cell responses in these large-size reactors. The future is still bright for
bio-based productions with the right products, robust microbial hosts, and cost-efficient process.
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